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tailpiece specifically affect NK cell function. Finally, we demonstrate that single molecules of myosin IIA
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Abstract 
 
ROLE AND REGULATION OF MYOSIN IIA IN NATURAL KILLER CELL 
CYTOTOXICITY 
Keri Sanborn 
Advisor: Dr. Jordan S. Orange 
 
Natural killer (NK) cells are lymphocytes of the innate immune system that provide 
defense by directing their cytotoxic activity against virally infected and tumorigenic cells.  
Target cell lysis requires directed secretion of lytic granule contents, including pore-
forming perforin and apoptosis-inducing granzymes, at the contact site.  During the 
formation of a mature immunological synapse (IS) with a target cell, an NK cell 
polymerizes filamentous actin (F-actin) at the contact site, which may serve as a barrier 
to secretion of lytic granules for cytotoxicity.  An actin-based motor protein, nonmuscle 
myosin IIA, has been demonstrated to be required for NK cell cytotoxic activity.  In this 
work, we examine the role of myosin IIA in NK cell cytotoxicity.  Through studies of 
primary human NK cells and NK cell lines, we find that myosin IIA associates with NK 
cell lytic granules.  This functional association is required for NK cell granule exocytosis 
because myosin IIA mediates an interaction of lytic granules with F-actin at the IS.  We 
find that NK cell cytotoxicity is impaired in patients with mutations in the myosin IIA 
heavy chain, and that mutations in the motor domain and nonhelical tailpiece specifically 
affect NK cell function.  Finally, we demonstrate that single molecules of myosin IIA 
associate with NK cell lytic granules via the nonhelical tailpiece of the myosin IIA heavy 
chain, and that this interaction requires phosphorylation of the tailpiece at Ser1943.  
Thus, we present a novel role for nonmuscle myosin IIA in NK cells, where myosin IIA 
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directly associates with lytic granules and guides their transport across actin filaments to 
facilitate secretion of their contents.
 
viii
 
Table of Contents 
Dedication .......................................................................................................... iv 
Acknowledgments .............................................................................................. v 
Abstract .............................................................................................................. vi 
List of Tables ..................................................................................................... xi 
List of Figures ................................................................................................... xii 
List of Abbreviations ....................................................................................... xiii 
List of Electronic Files ..................................................................................... xv 
Chapter 1: Introduction ...................................................................................... 1 
Summary ................................................................................................................... 1 
Introduction: cell-mediated immunity ..................................................................... 1 
Steps leading to natural killer cell cytotoxicity ...................................................... 3 
Adhesion and activation .......................................................................................... 3 
Immunological synapse formation and maturation .................................................. 3 
Commitment to target cell lysis: Movement of granules and the MTOC .................. 5 
Lytic granule approximation to the membrane and accessing cytotoxicity from the 
membrane-approximated granule ........................................................................... 7 
Steps following lytic granule polarization toward the immunological synapse ... 8 
Actin as a barrier to directed secretion .................................................................... 9 
Mechanisms of lytic granule access to the synaptic plasma membrane .................10 
The role of myosin IIA in NK cell lytic granule exocytosis ...................................11 
Introduction to the myosin superfamily ...................................................................11 
Nonmuscle myosin IIA ...........................................................................................13 
Regulation and inhibition of myosin IIA ..................................................................14 
Roles for myosin IIA in cell polarity and division .....................................................17 
Roles for myosin IIA in cell migration and adhesion ...............................................18 
Roles for myosin IIA in organelle transport and secretion ......................................20 
MYH9-related disease ...........................................................................................23 
Requirement for myosin IIA function in NK cell cytotoxicity ....................................24 
Thesis objectives .....................................................................................................25 
Chapter 2: Myosin IIA associates with NK cell lytic granules to enable their 
interaction with F-actin .................................................................................... 26 
Summary ..................................................................................................................26 
Introduction .............................................................................................................27 
Results .....................................................................................................................29 
Human NK cells with a myosin IIA 1933x mutation have reduced cytotoxicity and 
lytic granule entry into F-actin at the IS ..................................................................29 
Myosin IIA is not required for IFN-γ secretion ........................................................33 
Myosin IIA and perforin colocalize in NK cells before and throughout IS formation 35 
Myosin IIA is associated with NK cell lytic granules ...............................................39 
Myosin IIA-associated lytic granules can bind F-actin ............................................43 
Myosin II function is necessary for lytic granule approach to the IS........................47 
 
ix
Discussion ...............................................................................................................50 
Chapter 3: Phosphorylation of the myosin IIA tailpiece regulates 
association of single myosin IIA molecules with NK cell lytic granules to 
promote NK cell cytotoxicity ........................................................................... 56 
Summary ..................................................................................................................56 
Introduction .............................................................................................................57 
Results .....................................................................................................................59 
Human NK cells with mutations in the myosin IIA head or tailpiece have impaired 
cytotoxicity. ............................................................................................................59 
The myosin IIA tailpiece is phosphorylated at Ser1943. .........................................62 
Phosphorylation of myosin IIA at Ser1943 is required for NK cell cytotoxicity. .......65 
Ser1943 phosphorylation mediates the interaction of myosin IIA with lytic granules.
 ..............................................................................................................................67 
Myosin IIA associates with lytic granules in single-molecule form via the tailpiece. 68 
Discussion ...............................................................................................................71 
Chapter 4: Discussion ...................................................................................... 77 
Summary ..................................................................................................................77 
Nature of myosin IIA association with lytic granules ............................................78 
Additional regulation of myosin IIA in NK cells .....................................................79 
Role of F-actin at the IS and mechanisms of myosin IIA function in secretion...81 
Requirement for myosin IIA in T cell vs. NK cell cytotoxicity...............................83 
Implications for patients with MYH9-RD ................................................................84 
Conclusions .............................................................................................................85 
Chapter 5: Materials and Methods .................................................................. 87 
Cells ..........................................................................................................................87 
Blood samples and ex vivo NK cell preparation. ....................................................87 
Cell lines. ...............................................................................................................88 
Flow cytometric, conjugation, and degranulation analyses. ....................................88 
NK cell functional assays........................................................................................90 
Myosin II inhibitors. ................................................................................................90 
51Cr release cytotoxicity assay. ..............................................................................90 
NK cell IFN-γ secretion. .........................................................................................90 
Biochemical assays .................................................................................................90 
Immunoprecipitation. .............................................................................................90 
Western blot. .........................................................................................................91 
Isolation of lytic granules from NK cells. .................................................................92 
Biotinylation of isolated lytic granules. ....................................................................92 
Serine esterase assay. ..........................................................................................93 
Actin-binding centrifugation assay..........................................................................93 
Actin-binding flow chamber assay. .........................................................................93 
Mass spectrometry. ...............................................................................................95 
Imaging and image analysis ...................................................................................95 
Fixed cell microscopy.............................................................................................95 
Live cell microscopy. ..............................................................................................97 
Total internal reflection fluorescence (TIRF) microscopy. .......................................97 
Electron microscopy (EM). .....................................................................................98 
STED microscopy. .................................................................................................99 
Statistical analysis...................................................................................................99 
 
x
References ...................................................................................................... 100 
 
 
xi
List of Tables 
Table 3.1. Mutations and phenotype of patients with MYH9-RD. ....................... 59 
 
xii
List of Figures 
Figure 1.1. Steps to the formation of the NK cell IS. ............................................. 4 
Figure 1.2. Two models of lytic granule access to the plasma membrane during 
cytotoxicity. .................................................................................................... 9 
Figure 1.3. Structure of nonmuscle myosin IIA. .................................................. 13 
Figure 2.1.  Effect of myosin IIA 1933x mutation on cytotoxicity and perforin 
localization at the IS. ................................................................................... 30 
Figure 2.2.  IS formation in NK cells with 1933x mutant myosin. ........................ 31 
Figure 2.3. Analysis of function and protein localization in NK cells from myosin 
IIA 1933x patients 1 & 3. ............................................................................. 34 
Figure 2.4. Effect of inhibition of myosin IIA on NK cell IFN- γ secretion. ........... 35 
Figure 2.5.  Expression and function of myosin IIA and perforin in unconjugated 
NK cells. ...................................................................................................... 36 
Figure 2.6. Myosin IIA colocalization with lytic granules. .................................... 38 
Figure 2.7.  Evaluation of fluorescence in fixed cell conjugates. ........................ 40 
Figure 2.8. Evaluation of myosin IIA in isolated NK cell lytic granules. ............... 42 
Figure 2.9. Biochemical analysis of myosin IIA accumulation in the lytic granule 
fraction (fraction 6) before and after physiologic YTS activation. ................. 44 
Figure 2.10. Ultrastructural localization of myosin IIA in NK cells and isolated lytic 
granules. ...................................................................................................... 45 
Figure 2.11.  Interaction between myosin IIA-associated lytic granules and F-
actin. ............................................................................................................ 46 
Figure 2.12.  Actin-coated microflow chambers. ................................................. 47 
Figure 2.13. Functional association of lytic granules with F-actin and effects of 
ATP and myosin IIA 1933x. ......................................................................... 48 
Figure 2.14.  Evaluation of myosin IIA in lytic granule dynamics. ....................... 49 
Table 3.1. Mutations and phenotype of patients with MYH9-RD. ....................... 59 
Figure 3.1.  Effect of naturally occurring mutations in MYH9 on human NK cell 
cytotoxicity. .................................................................................................. 60 
Figure 3.2.  Expression of GFP-tagged myosin IIA and mutants. ....................... 61 
Figure 3.3.  The 1933x mutation in MYH9 reduces NK cell killing. ..................... 62 
Figure 3.4.  Myosin IIA is constitutively phosphorylated at Ser1943. .................. 64 
Figure 3.5.  Myosin IIA phosphorylation at Ser1943 is required for NK cell 
cytotoxicity, but not IFN-γ secretion. ............................................................ 66 
Figure 3.6.  Expression of myosin IIA mutants does not affect conjugation with 
target cells. .................................................................................................. 67 
Figure 3.7.  Ser1943 is a major site of phosphorylation in myosin IIA. ............... 68 
Figure 3.8.  The myosin IIA tailpiece and S1943 phosphorylation are required for 
its interaction with lytic granules. ................................................................. 69 
Figure 3.9.  Single molecules of myosin IIA associate with NK cell lytic granules.
 .................................................................................................................... 71 
 
 
xiii
List of Abbreviations 
Abbreviation Full Name 
1933x  Myosin IIA mutation causing truncation at residue 1933 
51Cr  Chromium radioisotope 
Ab  Antibody 
ADP  Adenosine diphosphate 
AMP  Adenosine monophosphate 
Arp  Actin related protein 
ASM  Acid sphingomyelin 
ATP  Adenosine triphosphate 
BDM  2,3-Butanedione monoxime 
BLT  N-a-Cbz-L-lysine thiobenzyl ester hydrochloride 
BSA  Bovine serum albumin 
CD  Cluster of differentiation 
CIP4  Cdc42-interacting protein 4 
CKII  Casein kinase II 
CLF  Crude lysosomal fraction 
cSMAC Central supramolecular activation cluster 
CTL  Cytotoxic T lymphocyte 
DMSO  Dimethyl sulfoxide 
DTNB  5,5’-dithiobis(2-nitrobenzoic acid) 
DTT  Dithiothreitol 
EBV  Epstein-Barr Virus 
ELISA  Enzyme-linked immunosorbent assay 
EM  Electron microscopy 
eNK  Ex vivo NK cell 
Erk  Extracellular signal related kinase 
F-actin  Filamentous actin 
FACS  Fluorescence activated cell sorting 
FCS  Fetal calf serum 
GFP  Green fluorescent protein 
GTP  Guanosine triphosphate 
GzmB  Granzyme B 
HBSS  Hank’s balanced salt solution 
HS1  Hematopoietic lineage cell specific protein 1 
ICAM-1 Intercellular adhesion molecule 1 
IFN-γ  Interferon gamma 
IL-2  Interleukin 2 
IS  Immune synapse 
KIR  Killer cell inhibitory receptor 
LAMP-1 Lysosomal associated membrane protein 1 
Lck  Lymphocyte-specific protein tyrosine kinase 
LFA-1  Lymphocyte function associated antigen 1 
LMM  Light meromyosin 
 
xiv
mAb  Monoclonal antibody 
MAC-1  Macrophage-1 antigen 
MHC  Major histocompatibility complex 
MLCK  Myosin light chain kinase 
MTOC  Microtubule organizing center 
Mts1  Metastasis-associated protein 1 
Munc  Mammalian uncoordinated  
MYH9  Myosin IIA heavy chain 
MYH9-RD MYH9- related disease 
MyoIIA  Myosin IIA 
MYPT  Myosin phosphatase 
NK  Natural killer 
NP-40  Nonidet P-40, octylphenoxypolyethoxyethanol 
PBMC  Peripheral blood mononuclear cell 
PBS  Phosphate buffered saline 
PHA  Phytohemagluttinin 
PKC  Protein kinase C 
PMA  Phorbol 12-myristate 13-acetate 
PNL  Post-nuclear lysate 
PP  Protein phosphatase 
pSMAC Peripheral supramolecular activation cluster 
Pyk2  Protein tyrosine kinase 2 
ROCK  Rho kinase 
RPMI  Roswell Park Memorial Institute 
S1943A Myosin point mutation of Ser1943 to Ala 
S2  Subfragment 2 
SA  Streptavidin 
SD  Standard deviation 
siRNA  Small interfering RNA 
SNARE Soluble N-ethylmaleimide-sensitive protein attachment protein 
receptor 
TBS  Tris buffered saline 
TCR  T cell receptor 
TIRF  Total internal reflection fluorescence 
TNF-α  Tumor necrosis factor α 
VAMP  Vesicle-associated membrane protein 
vMALDI Vacuum matrix-assisted laser desorption 
WASp  Wiskott Aldrich syndrome protein 
WAVE  WASp family verprolin homologous protein 
WCL  Whole cell lysate 
WIP  WASp interacting protein 
 
 
xv
List of Electronic Files 
File Format Size 
Video 1A QuickTime Movie 1.5 MB 
Video 1B QuickTime Movie 1.7 MB 
Video 1C QuickTime Movie 1.7 MB 
Video 1D QuickTime Movie 1.2 MB 
Video 1E QuickTime Movie 1.4 MB 
Video 1F QuickTime Movie 1.4 MB 
Video 2 QuickTime Movie 932 KB 
Video 3 QuickTime Movie 900 KB 
Video 4A QuickTime Movie 3.3 MB 
Video 4B QuickTime Movie 9.9 MB 
Video 4C QuickTime Movie 5.5 MB 
Video 4D QuickTime Movie 8.1 MB 
Video 5A QuickTime Movie 2.9 MB 
Video 5B QuickTime Movie 25 MB 
Video 6A QuickTime Movie 3.2 MB 
Video 6B QuickTime Movie 3.7 MB 
Video 7A QuickTime Movie 1 MB 
Video 7B QuickTime Movie 788 KB 
   
 
 
 
1
Chapter 1: Introduction1 
Summary 
 Natural killer (NK) cells have an inherent ability to recognize and destroy a wide 
array of cells rendered abnormal by stress or disease.  NK cells can kill a targeted cell 
by forming a tight interface rich in filamentous actin (F-actin) - the lytic immunological 
synapse (IS).  This represents a dynamic molecular arrangement that over time 
progresses through a series of steps to ultimately deliver the contents of specialized 
organelles known as lytic granules.  In order to mediate cytotoxicity, the NK cell must 
mobilize the lytic granules, polarize them to the targeted cell, facilitate their 
approximation to the NK cell membrane, and release their contents.  This thesis focuses 
on the challenge of secreting NK cell lytic granules through the dense layer of F-actin at 
the IS, and in particular the role of the actin motor protein nonmuscle myosin IIA in this 
process. 
Introduction: cell-mediated immunity 
 NK cells are the major lymphocytes of the innate immune system that provide critical 
defense against cancerous and virally infected cells. NK cells are orchestrators of 
immune responses, providing costimulation for other cells and producing cytokines such 
as interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) (reviewed in 
(Orange and Ballas, 2006)).  The importance of NK cells in combating viruses and tumor 
cells is revealed by the fact that patients with NK cell deficiencies are highly susceptible 
to herpesviruses and certain types of cancers (Orange, 2006).  While NK cell activation 
                                                        
1 Parts of this chapter have been published as: 
 
Sanborn KB, Orange JS. 
Navigating Barriers: the challenge of directed secretion at the natural killer cell lytic immunological 
synapse. 
Journal of Clinical Immunology.  May 2010; Volume 30, pp.358-363. 
 
 
2
is important for defense against cancer and pathogens, over-activation of NK cells has 
been connected to autoimmune and inflammatory diseases (Perricone et al., 2008), and 
thus NK cell activity must be carefully regulated.  
 While their counterparts in the adaptive immune system, CD8+ T cells, utilize 
recombination for the creation of antigen-specific activation receptors, NK cells are 
instead activated by germline-encoded receptors for common intracellular antigens and 
ligands upregulated on infected and cancerous cells (reviewed in (Biassoni, 2009) and 
(Vivier et al., 2008)).  Because they contain many diverse activation receptors, NK cells 
also express a family of inhibitory receptors, which recognize self major 
histocompatibility complex (MHC) proteins, to prevent NK cells from becoming activated 
by normal cells.  When the balance of activation and inhibition is tipped towards 
activation, NK cells are activated to kill infected or cancerous target cells.  
 The most critical function of NK cells, as well as CD8+ T cells, during elimination of 
infected or transformed target cells is lytic granule-mediated cytotoxicity. Lytic granules 
are specialized organelles, a form of secretory lysosomes, containing the pore-forming 
molecule perforin and cell death-promoting molecules such as granzymes (Kupfer et al., 
1991).  It was initially thought that perforin created a pore in the outer cell membrane 
that allowed granzymes to enter the target cell and activate the caspase cascade to 
promote target cell apoptosis (Tschopp et al., 1986).  Recent work, however, suggests a 
different mechanism, where perforin polymerization on the target cell membrane causes 
a brief influx of calcium into the target cell, which initiates clathrin-mediated endocytosis 
of both perforin and granzymes as part of the membrane-repair response (Thiery et al., 
2010).  Once perforin and granzymes are endocytosed together, perforin releases 
granzymes from the large endosomes (or “gigantosomes”), and granzymes initiate cell 
death.  The importance of this process is highlighted by the susceptibility of perforin-
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deficient human patients and mice to viral infections and cancer (Kagi et al., 1994; Stepp 
et al., 1999).  
Steps leading to natural killer cell cytotoxicity 
 Upon recognizing target cells using their germline-encoded activation receptors, NK 
cells promote host defense by lysing these cells via the secretion of lytic granule 
contents.  This process, termed directed secretion, begins with the formation of an 
immunological synapse at the contact site between an NK cell and a target cell. 
Adhesion and activation 
 NK cell activation takes place in a tightly regulated series of stages (Figure 1.1).  
When an NK cell first encounters a potentially transformed or infected target cell, 
receptors strengthening the interaction between the effector and target cells are ligated.  
Selectins and integrins, such as L-selectin, LFA-1, and MAC-1, have been implicated in 
the initial adhesion step, and are required for effective conjugation between NK cells and 
their targets (Chen et al., 2005; Davis et al., 1999; Orange et al., 2003; Vyas et al., 
2001).  This adhesion allows for activation receptors on the NK cell, such as natural 
cytotoxicity receptors and activating killer cell immunoglobulin-like receptors (KIRs), to 
focus in the direction of the target cell. In NK cells, activation signaling can be 
balanced by inhibitory signaling, often from inhibitory KIRs recognizing self MHC 
molecules (Eissmann and Davis).  If the balance of activation and inhibition leans 
towards activation, the NK cell is activated to progress through further steps in maturing 
a lytic interface with its target and thus initiate steps to kill the dangerous cell.  
Immunological synapse formation and maturation 
 Following adhesion and activation signaling, the NK cell forms a tight interface with 
the target cell, known as the immunological synapse (IS).  This process is initially 
mediated by members of the integrin family of adhesion molecules, which cluster at the 
contact site and utilize a higher-affinity conformation to promote firm adhesion and 
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adhesion signaling (Barber et al., 2004; Davis et al., 1999; Orange et al., 2003; Vyas et 
al., 2001).  The IS is the site of actin polymerization and reorganization (Carpen et al., 
1983), which require the activity of guanine exchange factor Vav1 to transmit activation 
signals, as well as actin nucleation by Arp2/3, WASp, and WAVE2 and stabilization of 
 
Figure 1.1. Steps to the formation of the NK cell IS.   
When an NK cell contacts a target cell, adhesion and activation receptors are ligated, causing 
the convergence of lytic granules to the MTOC (A, left).  As signaling increases past an 
activation threshold, the MTOC moves along with associated lytic granules toward the IS, and 
actin polymerizes at the contact site (A, middle).  Actin polymerization and lipid raft 
polarization at the IS increases as the IS matures, and lytic granules reach the IS with the 
MTOC (A, right).  During the effector phase (B), lytic granules exhibit myosin IIA-mediated 
motility toward an area of actin hypodensity, but not absence (left), and granule contents, 
including perforin and granzymes, are secreted at the IS to effect target cell lysis (right).  
When the target cell initiates apoptosis, the NK cell detaches and recycles granule membrane, 
preparing to lyse another target (C). 
 
Figure adapted from Orange JS, “Formation and function of the lytic NK-cell immunological 
synapse,” Nature Reviews Immunology, September 2008 
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nascent filaments by HS1 (Barber et al., 2004; Butler et al., 2008; Graham et al., 2006; 
Orange et al., 2002; Orange et al., 2011).  Actin polymerization at the IS improves the 
stability of the contact by allowing the NK cell to undergo shape changes to closely hug 
the target cell (Orange et al., 2003; Wulfing et al., 2003).   Without the ability to 
reorganize F-actin, NK cells are not able to focus receptors and lipid rafts to the interface 
or polarize lytic granules toward the IS for secretion (Butler and Cooper, 2009; Graham 
et al., 2006; Masilamani et al., 2006; Orange et al., 2003; Wulfing et al., 2003), which 
suggests that F-actin polymerization at the IS represents an early step in the process of 
cytotoxicity.  Once F-actin polymerization at the IS begins, the contact site organizes into 
several discrete zones, including a ring of F-actin and integrins at the periphery, known 
as the peripheral supramolecular activation cluster (pSMAC), and a cluster of critical 
signaling molecules at the central region of the interface, known as the central 
supramolecular activation cluster (cSMAC).  While in T cells, it is known that 
microclusters of T cell receptor (TCR) signaling complexes move from the pSMAC to the 
cSMAC during signal propagation (Varma et al., 2006), microclusters have only begun to 
be examined in NK cells (Treanor et al., 2006).  Additionally, the cSMAC may be more 
important for downregulation of signaling, as TCR microclusters are ubiquitinized and 
degraded during activation (Vardhana et al., 2010).   Although the purpose of 
organization into the pSMAC and cSMAC is debated and likely differs between cell 
types, proper organization of the synapse is thought to be required for directed secretion 
of lytic granules in NK cells (Bryceson et al., 2005; Stinchcombe et al., 2001b). 
Commitment to target cell lysis: Movement of granules and the MTOC 
 Once an organized IS is formed, adhesion and activation signaling are further 
amplified, finally reaching an activation threshold which directs the NK cell to commit to 
secreting lytic granule contents.  In order for this form of directed secretion to occur, the 
microtubule organizing center (MTOC) and lytic granules must polarize to the IS.    
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Movement of the MTOC to the IS is known to depend upon Lck, ERK, Vav1, Pyk2, and 
hDia1 and Lck signaling (Butler and Cooper, 2009; Chen et al., 2006; Graham et al., 
2006; Sancho et al., 2000; Tsun et al., 2011), and stabilization of the MTOC and at the 
IS depends upon CIP4 (Banerjee et al., 2007), but details of this movement are still 
unclear. One important signal for granule polarization to the IS in NK cells appears to be 
integrin signaling, as isolated ICAM-1 signaling through LFA-1 can induce granule 
polarization (Bryceson et al., 2005), although in T cells integrin signaling may not be 
necessary (Beal et al., 2009).  In T cells, the movement of lytic granules and the MTOC 
to the IS is thought to occur in two possible ways, which are dependent upon strength of 
signal (Beal et al., 2009; Jenkins et al., 2009).  When a strong signal is received, lytic 
granules are delivered quickly to the IS in a focused manner, but when altered peptide 
ligands for the T cell receptor are used experimentally, polarization is less focused. 
 Whether NK cells use these methods of granule delivery to the IS remains unknown, 
however, evidence from our laboratory defines a rapid approximation of lytic granules to 
the MTOC prior to their delivery to the IS (Mentlik et al., 2010).  When an NK cell 
contacts a potentially dangerous target cell, initial adhesion signaling through integrins, 
independent of activation signaling, induces lytic granule convergence along 
microtubules to the MTOC as an initial preparatory step for NK cell cytotoxicity.  If 
activation signaling occurs, the MTOC polarizes towards the target cell along with lytic 
granules to allow lytic granule contents to be secreted.  If the interaction is inhibitory, 
however, no MTOC polarization occurs and the target cell is not killed.  In this work, the 
movement of lytic granules along microtubules was shown to be dynein-dependent, thus 
demonstrating dynein as a minus-ended microtubule motor for lytic granules, suggesting 
that dynein directly moves the granules along microtubules toward the MTOC (Mentlik et 
al., 2010). The lysosomal sorting protein AP3 is also required for granule movement to 
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the IS (Clark et al., 2003), likely due to a role in sorting a protein required for movement 
rather than a direct motor function. 
Lytic granule approximation to the membrane and accessing cytotoxicity from the 
membrane-approximated granule 
 Once NK cell lytic granules gain access to the plasma membrane, they must fuse 
with the membrane to allow for the secretion of their contents.  This appears to be a 
multi-step process, involving tethering, vesicle priming, and membrane fusion.  In CTLs, 
the small GTPase rab27a has been shown to link lytic granules as cargo to their target 
membranes (Stinchcombe et al., 2001a).  This tethering step appears to be necessary 
for granule approximation to the plasma membrane.  Once granules are tethered to the 
membrane, they must be prepared for fusion.  Munc13-4, a binding partner of rab27a, 
has a critical role in vesicle priming for lytic granule exocytosis in CTLs and mast cells 
(Neeft et al., 2005), and although levels of Munc13-4 are reduced in NK cells compared 
to T cells (Neeft et al., 2005), the protein has been shown to interact with rab27a in NK 
cells as well (Menager et al., 2007).  Fusion of lytic granules with the membrane is 
regulated by soluble N-ethylmaleimide-sensitive protein attachment protein receptor 
(SNARE) proteins, which target granules to the correct portion of the membrane for 
fusion.  SNARE-related proteins required for NK cell cytotoxicity include VAMP7, which 
associates with lytic granules (Marcet-Palacios et al., 2008), as well as syntaxin-11 and 
Munc18-2, which interact with each other to drive membrane fusion for lytic granule 
exocytosis in NK cells (Arneson et al., 2007; Bryceson et al., 2007; Cote et al., 2009).  
These proteins are defective in a series of human diseases resulting from impaired 
degranulation (reviewed in (Orange, 2008)).  The proteins which mediate granule 
tethering, priming, and membrane fusion may be differentially recruited depending on 
strength or type of activation signal, serving as an additional layer of regulation for the 
process of exocytosis (Liu et al., 2009).   
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 Once lytic granules fuse with the plasma membrane, their membrane may need to 
contract in order to facilitate the secretion of their contents.  This process has been 
shown in CD8+ T cells to involve acid sphingomyelinase (ASMase), an enzyme which 
alters the composition of the membrane, forming ceramide, which curves the membrane 
to cause contraction (Herz et al., 2009).  Although it is not yet clear whether ASMase is 
important in NK cells, it is likely that a similar mechanism occurs to direct NK cell granule 
exocytosis.  Once the lytic granules have contracted to release their contents, perforin 
and granzymes work together to effect the lysis of target cells (discussed earlier and 
reviewed extensively in (Hoves et al., 2009)).  This process occurs in and is likely 
facilitated by a cleft formed between the NK cell and target cell, which likely serves the 
function of focusing these elements to the targeted cell (McCann et al., 2003). Following 
the secretion of granule contents, granule membrane proteins are internalized in a 
recycling process, allowing NK cells to create new lytic granules, thus recharging the 
cytotoxic capacity for serial killing of targets (Liu et al., 2009). 
Steps following lytic granule polarization toward the immunological synapse 
 Although lytic granules approximate the membrane by association with the MTOC, 
there may be additional obstacles for polarized granules to overcome prior to priming, 
docking, and fusion with the plasma membrane.  In activated NK cells, the F-actin cortex 
at the IS is dense and may present a barrier to secretion.  Several questions remain 
regarding this step of directed secretion: How do NK cell lytic granules reach the plasma 
membrane upon arriving at the IS?  How is F-actin cleared away for secretion and is this 
a necessary component for secretion?  If so, are the clearances sufficient for granule 
fusion with the membrane, or are additional motor molecules required?  Several recent 
findings have begun to mold our understanding of this part of the process and provide 
pieces to the complex puzzle of lytic granule exocytosis. 
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Actin as a barrier to directed secretion 
 Once lytic granules are delivered to the IS by the microtubule network, they 
encounter a dense F-actin cortex.  An effective activating IS in NK cells requires 
extensive actin polymerization, and without this polymerization, the MTOC and lytic 
granules do not polarize in the direction of the target cell (Graham et al., 2006; Orange 
et al., 2003; Wulfing et al., 2003).  Proteins like Arp2/3, WASp, and HS1 help to promote 
actin-mediated signaling through branching of the F-actin network, resulting in a 
meshwork of actin filaments at the IS (reviewed in (Burkhardt et al., 2008; Orange, 
2008)).  Although precise measurements of the actin gathered at the IS have not been 
performed, fluorescent images indicate that this layer of actin is dense (Huang et al., 
2005; McCann et al., 2003; Orange et al., 2003).  This amount of actin could act as a 
substantial physical barrier to the secretion of lytic granule contents (Figure 1.2).  
 
 
Figure 1.2. Two models of lytic granule access to the plasma membrane during 
cytotoxicity.  
If a central clearance in actin forms when an NK cell contacts a target cell (A), lytic 
granules can access the plasma membrane upon polarization to the IS.  If, instead, actin 
is not completely cleared from the contact site (B), actin acts as a barrier to secretion of 
lytic granule contents. 
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Granules may therefore require a combination of actin clearance mechanisms and 
additional, F-actin-based, motor molecules to reach the plasma membrane.  
Mechanisms of lytic granule access to the synaptic plasma membrane 
 One potential mechanism for allowing granules access to the membrane is the 
creation of large clearances in F-actin (Figure 1.2A).  Similar to T cells, F-actin 
clearances in the cSMAC region of the IS have been reported in NK cells (Andzelm et 
al., 2007; Orange et al., 2003; Roda-Navarro et al., 2004; Vyas et al., 2001).  While the 
formation of the actin clearance is known to be independent of microtubule integrity and 
MTOC polarization (Orange et al., 2003), it has not yet been shown whether actin 
hypodensity in the cSMAC occurs as a result of symmetrical actin reorganization in the 
pSMAC region, or if the clearances are actively created by bundling or depolymerizing 
actin filaments in the cSMAC.  While several proteins, including the actin-associating 
protein HS1 and the activation receptor NKG2D, have been implicated in IS symmetry 
during cell spreading (Butler et al., 2008; Culley et al., 2009), in cells with perturbed actin 
dynamics, a central clearance is typically still evident.  Additionally, it remains unknown 
whether any clearance in F-actin is long-lasting, or simply a transient effect during initial 
NK cell:target cell conjugation. 
 Recent data demonstrate that lytic granules reach the IS through travel with the 
MTOC (Mentlik et al., 2010; Stinchcombe et al., 2006).  While there is evidence that 
granules reach the plasma membrane in T cells via their association with the MTOC, 
and do not require any additional form of microtubule-based or actin-based transport 
(Stinchcombe et al., 2006), it remains unclear whether all lytic granule transport to the IS 
from the MTOC is a feature of intimate MTOC approximation to the IS and independent 
of non-MTOC-associated motor molecules.  Lytic granule transport in NK cells has been 
shown to be capable of occurring in the direction of microtubule plus-ends using the 
microtubule motor kinesin (Burkhardt et al., 1993), and has been shown to require the 
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actin motor myosin IIA ((Andzelm et al., 2007) and Chapters 2 & 3), suggesting that NK 
cell degranulation may require motor molecules following polarization of granules to the 
IS.   
The role of myosin IIA in NK cell lytic granule exocytosis 
 Recently, a role for the actin motor protein myosin IIA has been shown in NK cell 
cytotoxicity ((Andzelm et al., 2007) and Chapters 2 & 3 of this thesis). The mechanism of 
this role for myosin IIA in NK cell cytotoxicity, and particularly in directing granule 
transport across F-actin at the IS, is the main focus of this thesis. 
Introduction to the myosin superfamily 
The myosin superfamily is a diverse group of actin-based molecular motors.  There 
are at least eighteen different classes of myosin (Berg et al., 2001; Foth et al., 2006), as 
defined by the ability to either translocate actin filaments or translocate cargo across 
actin filaments (Sellers, 1999).  All members of the myosin superfamily are able to 
reversibly bind actin and hydrolyze MgATP, which allows them to use ATP hydrolysis as 
an energy source for their movement along actin filaments.  In many types of myosin, 
MgATP hydrolysis is regulated by either phosphorylation or the presence of calcium ions 
(Sellers, 1999). 
Although the specific mechanisms of their actin motor function differ by class, all 
myosins have a general structure in common.  The head domain, which is typically at the 
N-terminus and is comprised of 720-830 amino acids, is the globular domain which is the 
site of actin binding and MgATP hydrolysis.  This motor domain is mostly conserved 
between myosin classes, particularly in the actin- and nucleotide-binding sites (Cope et 
al., 1996; Goodson and Spudich, 1993).  The neck region is a long α-helical region that 
generally regulates myosin motor function through the association of light chains or 
calmodulin (Sellers, 2000).  The tail, which is the least conserved portion of myosin, 
typically consists of an α-helical rod and nonhelical portion, and is critical for anchoring 
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myosin to enable movement along filaments (Sellers, 1999).  In myosin II, the tail is also 
important for self-association into filaments ((Franke et al., 2005), reviewed in (Eddinger 
and Meer, 2007; Ricketson et al., 2010)).  Other structural aspects, including neck and 
tail length, as well as the number of heads in each molecule, differ between myosin 
classes. 
The structure of myosin molecules is designed to couple ATP hydrolysis to 
conformational changes which generate myosin motor function (Alberts, 2002).  When a 
myosin molecule, bound by its tail region to either cargo or other myosin molecules, 
interacts with an actin filament, it binds along the side of the filament in a rigor 
conformation, with the head tightly locked to the actin filament.  When ATP binds to the 
myosin head, a conformational change causes myosin to dissociate from the actin 
filament.  ATP hydrolysis causes a larger conformation change, where the myosin head 
rotates, re-binding to actin at a position further along the filament.  Release of the 
phosphate group following hydrolysis allows for myosin to bind more tightly to the actin 
filament, generating force in what is known as the “power stroke.”  This force can either 
translocate actin filaments, if the myosin tail is bound to a stationary object, or move 
cargo along the actin filament, if the myosin tail is bound to a vesicle or small cargo.  
Although the subclasses of myosin differ in structure, all move along the actin filament in 
the direction of the plus end, with the exception of myosin VI, which is a minus end 
directed actin motor (Menetrey et al., 2005; Wells et al., 1999). 
The myosin superfamily is separated into subclasses by two different classifications.  
First, the term “conventional myosins” is used to describe myosin II family members, as 
these were first described in their role in muscle contraction, while all other myosin 
classes are considered “unconventional myosins.”  Second, myosins can also be 
described by the location in which they function most often; thus, there are skeletal 
muscle myosins, smooth muscle myosins, and nonmuscle myosins (Sellers, 1999). 
 
13
This thesis focuses specifically on the role of nonmuscle myosin IIA, and therefore 
while other types of myosin may be important in the activities examined, only myosin IIA 
will be discussed in detail.  
Nonmuscle myosin IIA 
 Nonmuscle myosin II proteins are heterohexameric proteins consisting of two heavy 
chains, two essential light chains, and two regulatory light chains (Figure 1.3).  Like most 
myosin classes, myosin II molecules have an N-terminal globular head region which is 
important for F-actin binding and ATP hydrolysis.  The neck region immediately following 
the head contains the binding sites for the light chains, while the S2 region following the 
neck is important for enabling the motion of the myosin head domain (Eddinger and 
Meer, 2007).  The C-terminal tail of myosin II molecules consists of a long α-helical 
coiled-coil rod domain, followed by a small, globular nonhelical tailpiece.  The rod 
domain of myosin II is important for self-association into filaments (Ricketson et al., 
2010), while the nonhelical tailpiece regulates filament assembly and cargo binding, and 
        
 
Figure 1.3. Structure of nonmuscle myosin IIA.  
Myosin IIA is a heterohexameric protein consisting of two heavy chains (orange/yellow) and 
four light chains (green).  The N-terminus, or head, region, is important for actin binding and 
ATP hydrolysis, while flexibility of the neck region is important to enable motor function.  The 
rod region consists of a coiled-coil of two α-helices and is important for filament formation, 
while the C-terminal non-helical tailpiece is critical for cargo binding and can also regulate 
filament formation. 
 
Figure adapted from Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P, Molecular 
Biology of the Cell, 4
th
 Edition.  New York: Garland Science, 2002. p.950 
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has been shown to be capable of directly binding to phospholipid membranes (Murakami 
et al., 1994; Ricketson et al., 2010). 
 The nonmuscle myosin II family consists of three members: myosin IIA, myosin IIB, 
and myosin IIC (Golomb et al., 2004; Shohet et al., 1989; Simons et al., 1991).  The 
three isoforms are extremely similar in head and S2 region sequences, as well as most 
of the coiled-coil regions (64-80% sequence homology (Ronen and Ravid, 2009)).  Their 
tailpiece regions vary significantly, however, and it is the tailpiece that appears to target 
each isoform to specific locations within the cell (Ronen and Ravid, 2009; Sandquist and 
Means, 2008).  The three isoforms are expressed variably in different tissues, and are 
regulated differently as well.  Myosin IIA is the main isoform expressed in hematopoietic 
cells (Kawamoto and Adelstein, 1991), and as such will be the focus of the remainder of 
the thesis. 
 The myosin IIA heavy chain, encoded by the gene MYH9 in humans, encodes a 227 
kDa peptide.  Its N-terminal head region ends at residue Lys835, transitioning into a 
coiled-coil rod consisting of an S2 region (the first third of the rod) and a light 
meromyosin region (through residue Pro1927).  Following the rod domain is a nonhelical 
tailpiece from Phe1928 to Glu1960 (Kopp, 2010; Kunishima et al., 2001a).  As it is a 
widely expressed protein, the roles for myosin IIA are constantly increasing, and new 
mechanisms for its function are still being uncovered.  Thus far, roles for myosin IIA 
have been demonstrated in cell polarity and division, adhesion and migration, and 
secretion, all of which will be discussed in later sections.   
Regulation and inhibition of myosin IIA 
 Regulation of myosin IIA primarily occurs through phosphorylation of the heavy and 
light chains.  The regulatory light chains are phosphorylated at residues Ser19 (and 
sometimes Thr18) by myosin light chain kinase (MLCK), Rho kinase (ROCK), protein 
kinase C (PKC), p21 kinase, and AMP-activated protein kinase, which has been shown 
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to regulate myosin motor function by increasing ATPase activity and promoting myosin 
filament formation (Adelstein and Conti, 1975; Amano et al., 1996; Bresnick, 1999). 
Phosphorylation at these sites is downregulated by myosin phosphatase (MYPT), which 
dephosphorylates myosin light chains.  Phosphorylation of the regulatory light chains 
also occurs at Ser1/2 and Thr9, which is attributed to PKC.  Phosphorylation by PKC 
inhibits the ATPase activity of myosin IIA by decreasing its affinity for actin and inhibiting 
MLCK phosphorylation of the light chains (Nishikawa et al., 1984). 
 Although the myosin IIA heavy chain contains 1960 amino acids and there are 42 
serine, 17 threonine, and 9 tyrosine residues that are identified by NetPhos to be 
predicted candidates for phosphorylation, phosphorylation of myosin IIA has been 
demonstrated to occur at very few residues.  PKC phosphorylates Ser1916 (in humans; 
1917 in some species) near the end of the coiled-coil rod domain (Conti et al., 1991), 
while casein kinase II phosphorylates Ser1943 (sometimes Ser1944) in the nonhelical 
tailpiece (Murakami et al., 1998).  Ser1916 phosphorylation has been demonstrated in 
human platelets (Conti et al., 1991), and has also been shown to be important in mast 
cell degranulation ((Ludowyke et al., 2006; Ludowyke et al., 1989; Ludowyke et al., 
1996), discussed later).  This residue is also phosphorylated in the Jurkat human CD4+ T 
cell line following treatment with phorbol 12-myristate 13-acetate (PMA), while Ser1943 
is constitutively phosphorylated in Jurkat cells (Moussavi et al., 1993).   Ser1943 
phosphorylation is also important in regulating chemotaxis in breast cancer cells 
(Dulyaninova et al., 2007). Thr1939 (sometimes Thr1940) phosphorylation has also 
been demonstrated in some systems (Buxton and Adelstein, 2000; Ludowyke et al., 
1989), and does have a role in T cell migration (Jacobelli et al., 2004), however, 
regulation at this residue is less common. 
 An additional mechanism of regulating myosin IIA is via interactions with other 
proteins.  One major binding partner for myosin IIA is the metastasis-associated protein 
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1, or mts1.  Mts1, also known as S100A4, was originally named for the correlation of 
high levels of expression with metastatic potential of tumor cells, however, it is also 
expressed at lower levels in normal cells.  In the presence of calcium, Mts1 binds to 
myosin IIA between residues 1909 and 1924 of the heavy chain (Kriajevska et al., 1998; 
Li et al., 2003), and can depolymerize myosin filaments (Ford et al., 1997) and sequester 
single myosin molecules, preventing formation of new filaments (Li et al., 2003; 
Malashkevich et al., 2008).  Mts1 binding also regulates the phosphorylation status of 
myosin IIA heavy chains by inhibiting PKC phosphorylation of Ser1916, and therefore 
can regulate filament formation in many ways (Kriajevska et al., 1998).  Interestingly, 
while PKC phosphorylation (at Ser1916, within the mts1 binding site) does not affect 
mts1 binding, a study by Dulyaninova, et al. demonstrates that CKII phosphorylation (at 
Ser1943, outside the binding site) protects against mts1 binding to the myosin IIA heavy 
chain (Dulyaninova et al., 2005).  While the mechanism for this is not yet clear, the 
authors speculate that phosphorylation at Ser1943 causes the tailpiece of myosin IIA to 
fold back onto the rod, blocking the binding site for mts1 (discussed further in Chapter 3 
of this thesis). 
 Although many attempts to understand the role of a specific protein begin with the 
construction of a mouse with a deletion in the gene of interest, a “knockout” of MYH9 is 
lethal at day 6.5 of embryonic development (Conti et al., 2004).  Therefore, many studies 
have relied upon inhibitors of the myosin II motor function to elucidate the role of myosin 
IIA in certain systems.  One of the earliest inhibitors used was 2,3-Butanedione 
monoxime (BDM), which was initially assumed to inhibit all myosin II ATPase activity but 
was later shown to inhibit only skeletal muscle myosin II (Ostap, 2002).  The MLCK 
inhibitors ML-7 and ML-9 were used to inhibit myosin II ATPase activity by blocking 
phosphorylation of the regulatory light chain (Saitoh et al., 1987).  These inhibitors are 
not considered to be specific myosin II inhibitors, however, as MLCK phosphorylates 
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proteins other than the myosin II light chains, and the inhibitors themselves have off-
target effects as well (Bain et al., 2003; Bain et al., 2007).  The most specific inhibitor 
currently used is blebbistatin (Straight et al., 2003), a small molecule inhibitor which 
binds to myosin II when its nucleotide binding cleft contains ADP and phosphate, 
slowing release of the phosphate molecule and therefore blocking myosin in a 
conformation with low affinity for actin (Allingham et al., 2005; Kovacs et al., 2004).  
Although all inhibitors have some off-target effects, blebbistatin has been shown to 
inhibit smooth muscle and nonmuscle myosin II without inhibiting class I, V, and X 
myosins (Limouze et al., 2004).  There are some limitations to use of the inhibitor, 
however, as blebbistatin is both photoinactivated and phototoxic when illuminated by 
wavelengths of light below 488 nm, making it impractical for use in some imaging 
experiments (Kolega, 2004; Sakamoto et al., 2005).  Therefore, ML-7 and ML-9 are still 
used in some experiments requiring the use of GFP or blue light.  Due to conservation of 
the head domain and ATPase activity between myosin II isoforms, all myosin II inhibitors 
will inhibit myosin IIA, IIB, and IIC.  While this is not a concern in some cell types due to 
the expression of only one isoform of myosin II, in others, siRNA is the best method of 
specifically inhibiting the function of one isoform without disrupting the others. 
Roles for myosin IIA in cell polarity and division 
Perhaps one of the most well-defined roles of myosin IIA is in cell polarity and 
division.  Remodeling of the actin cytoskeleton is critical for the maintenance of cell 
polarity, and myosin is often used by cells to generate the force necessary to translocate 
bundled actin filaments.  In epithelial cells, the ability of myosin IIA to drive contraction is 
important for the stability of cell-cell junctions and for contact inhibition (Carmona-
Fontaine et al., 2008; Yamada and Nelson, 2007).  Myosin IIA-mediated contractility is 
also important in the response to substrate stiffness and mechanical cues, which direct 
cell polarity and development (reviewed in (Clark et al., 2007)). Additional roles for 
 
18
myosin II exist in directing the positioning of the mitotic spindle and cleavage furrow in 
dividing cells, where the balance of myosin activity on each side of a dividing cell 
determines whether a cell divides symmetrically or asymmetrically (Ou et al., 2010; 
Weber et al., 2000). Because cell polarization during division is critical for differentiation, 
myosin II activity has been shown to be required for embryogenesis and development 
(reviewed in (Conti and Adelstein, 2008)).  While a complete discussion of the roles of 
myosin II in cytokinesis is beyond the scope of this thesis, the topic has been the subject 
of recent reviews (Burgess, 2005; Matsumura, 2005). 
Roles for myosin IIA in cell migration and adhesion 
Myosin IIA is an important regulator of cell migration due to its role in adhesion and 
cell polarity (Vicente-Manzanares et al., 2009).  Cell migration is characterized by the 
formation of new adhesions and remodeling of the actin cytoskeleton to generate 
movement.  A migrating cell typically has two actin-containing structures at the leading 
edge of the cell, the lamellipodium and the lamellum.  Branched actin polymerization 
driven by Arp2/3 generates the lamellipodium at the leading edge, while thicker bundles 
of actin filaments form the adjacent lamellum (Pollard and Borisy, 2003).  Although 
retrograde flow of actin occurs in both zones, the flow is slower in the lamellum.  At the 
area of convergence between the lamellipodium and the lamellum, actin reorganization 
is critical for generation of movement in the cell (Ponti et al., 2004).  Myosin II has been 
proposed to have a role in generation of retrograde actin flow in the lamellum, as 
inhibition of myosin II with blebbistatin decreases the rate of actin flow there (Cai et al., 
2006; Medeiros et al., 2006; Ponti et al., 2004).  While inhibiting myosin II increases 
protrusiveness in the cell, this does not mean the role of myosin in migration is inhibitory; 
myosin II-mediated remodeling of actin in the lamellum can serve to control the motion of 
the cell, allowing the cell to migrate in a directed fashion.  Additionally, myosin II activity 
is required for the maturation of nascent adhesions in the lamellipodium, perhaps due to 
 
19
its ability to stabilize actin filament bundles and therefore cluster important adhesion 
proteins (Choi et al., 2008; Humphries et al., 2007), or more directly due to its role in 
activating adhesion proteins (del Rio et al., 2009; Friedland et al., 2009).  At the same 
time, in the trailing edge of a migrating cell, myosin II activity is responsible for breaking 
adhesions and disassembling the actin network, therefore mediating retraction of the 
trailing edge (Chrzanowska-Wodnicka and Burridge, 1996; Wilson et al., 2010).  Myosin 
II is also important for the response to mechanical cues from the environment, and 
therefore has a role in determining the direction of migration (reviewed in (Clark et al., 
2007)).  The roles of different myosin II isoforms in cell migration vary, as the isoforms 
are differentially regulated ((Betapudi, 2010; Sandquist and Means, 2008), reviewed in 
(Conti and Adelstein, 2008)). 
Recently, a role for myosin IIA has been characterized in T cell migration (Ilani et al., 
2009; Jacobelli et al., 2009; Jacobelli et al., 2004; Jacobelli et al., 2010).  When 
performing immune surveillance, a migrating T cell holds a characteristic “hand-mirror” 
shape, consisting of leading edge protrusions and a smaller trailing edge, also called a 
uropod ((McFarland and Heilman, 1965), reviewed in (Burkhardt et al., 2008)). When T 
cells encounter their cognate antigen, they stop migrating, round up, and form an 
immunological synapse with the antigen-presenting cell, or APC (Negulescu et al., 
1996).  In migrating T cells, myosin IIA is enriched in the uropod (Jacobelli et al., 2004), 
where it associates with the integrin LFA-1 (Morin et al., 2008).  The interaction of 
myosin IIA with LFA-1 helps to mediate the de-adhesion of LFA-1 on ICAM-1 substrates, 
allowing for retraction of the uropod.  Crawling T cells treated with myosin II inhibitors or 
myosin IIA siRNA do not migrate properly, either becoming entirely non-motile (Jacobelli 
et al., 2004) or becoming consistently more elongated, if they are migrating across LFA-
1 ligands (Morin et al., 2008).  This interaction between myosin IIA and LFA-1 may be 
more complex, however, as more recent reports suggest that they mediate two 
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independent modes of migration in T cells, with myosin IIA controlling faster, “amoeboid” 
motility and LFA-1 directing a “sliding” motility dependent on a single moving adhesion 
(Jacobelli et al., 2009; Jacobelli et al., 2010).  When T cells stop migrating and form a 
contact with an APC, myosin IIA relocalizes from the uropod to the IS, a process which 
is mediated by phosphorylation of Thr1939 of the myosin IIA heavy chain (Jacobelli et 
al., 2004).  While ATPase activity isn’t required for the accumulation of myosin IIA at the 
IS, and IS formation occurs independently of myosin IIA, myosin IIA is necessary for T 
cell signaling downstream of Lck, and therefore for stability of the IS during T cell 
activation (Ilani et al., 2009; Jacobelli et al., 2004).  Whether this role for myosin IIA is 
unique to T cells or similar in NK cells remains to be determined; while IS formation is 
intact in NK cells following myosin IIA inhibition or silencing (Andzelm et al., 2007), the 
role of myosin IIA in NK cell migration has not yet been examined. 
Roles for myosin IIA in organelle transport and secretion 
A less well-defined role for myosin IIA exists in organelle transport and directed 
secretion.  While inhibition of myosin II reduces directed secretion in several systems 
(discussed below), the specific role for myosin in secretion appears to be variable.  In 
recent years, two main options for the mechanism of myosin function in secretion have 
emerged: indirect promotion of secretion through cytoskeleton reorganization, and direct 
facilitation of organelle transport. 
In some cell types, myosin II appears to have a more indirect role in secretion, 
namely in facilitating the creation, expansion, or maintenance of clearances in F-actin to 
allow for vesicle secretion.  This mechanism has been demonstrated in cortical granule 
exocytosis in zebrafish eggs, where myosin II is involved in remodeling the cytoskeleton 
around areas of secretion (Becker and Hart, 1999).  Myosin II activity is also required for 
the expansion and maintenance of fusion pores in chromaffin cells, which allows for the 
secretion of catecholamine in these cells (Berberian et al., 2009; Neco et al., 2008).  A 
 
21
similar role has been described in pancreatic acinar cells, a specialized type of epithelial 
cell that also requires a fusion pore for secretion (Bhat and Thorn, 2009).  Myosin IIA 
has also been described to have an indirect role in mast cell secretion.  While 
phosphorylation of myosin IIA occurs at the peak of degranulation in mast cells 
(Ludowyke et al., 2006), and phosphatases PP1 and PP2A associate with myosin at the 
same time (Holst et al., 2002), the authors of these studies speculate that the role for 
myosin is in remodeling the cytoskeleton for granule secretion rather than in directly 
guiding motility of mast cell granules.  Actin remodeling is not directly evaluated in these 
cells, however, and therefore the specific mechanism for myosin IIA in mast cell 
secretion remains unclear. 
In other systems, myosin II has been demonstrated to directly associate with the 
organelles to be secreted, and to be involved in their secretion. Myosin II has been 
shown to associate with vesicles derived from the Golgi (Fath, 2005; Ikonen et al., 
1997), and while its role in transport of these vesicles is debated (Ikonen et al., 1996; 
Simon et al., 1998), some studies suggest that myosin IIA may be involved in the 
transport of these vesicles from the Golgi to the plasma membrane ((Musch et al., 1997; 
Stow et al., 1998), reviewed in (DePina and Langford, 1999)). Although myosin IIA is 
thought to regulate the fusion pore in chromaffin cells (Berberian et al., 2009; Neco et 
al., 2008), it may also direct vesicle transport in these cells (Neco et al., 2004).  An 
association of myosin II with secretory vesicles has been demonstrated in diverse cell 
types, including human and bovine retinal pigmented epithelial cells (Linz-McGillem and 
Alliegro, 2003), clam and frog oocytes (DePina et al., 2007; Yu and Bement, 2007), and 
Drosophila neurons (Seabrooke et al., 2010).  In the cases of clam oocyte extracts and 
Drosophila neurons, inhibition of myosin II activity reduced the motility of vesicles, either 
in vitro or in vivo.  Although myosin IIA has not classically been known as a processive 
motor for organelle transport (see below), the direct association of myosin IIA with 
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vesicles for exocytosis and its role in their motility on actin filaments suggest an 
unconventional role for myosin IIA in these systems. 
Typically, organelle transport across actin filaments is thought to be mediated by 
other myosins, such as myosins V and VI, which have well-characterized cargo binding 
domains in the tail region and lever arms long enough to support processivity of the 
motor over long stretches of actin.  As a plus-ended actin motor, myosin V has important 
roles in exocytosis in cells as diverse as neuroendocrine cells and melanocytes (Eichler 
et al., 2006; Kural et al., 2007).  Myosin VI, the only known minus end-directed actin 
motor, is well known for its role in endocytosis (Altman et al., 2007; Buss et al., 2002; 
Buss et al., 2004; Hasson, 2003).  Although many systems rely on these motors for 
transport, there are some systems in which other myosin isoforms can be used, even if 
their conformation is less than ideal for organelle transport.  Motor molecules, like 
myosin II, that lack processivity over long distances can still direct motion over a 
distance, provided that enough motors exist on the cargo that at least one is in contact 
with the track at all times (Gross et al., 2007).  In this way, myosin II molecules could be 
used to direct organelle transport, at least over short distances.  Furthermore, although 
myosin II has always been characterized as a non-processive motor, recent data 
suggest that myosin IIB is, in fact, processive over short distances (Norstrom et al., 
2010).  Although the authors of this study indicate that this property is unlikely to exist in 
myosin IIA, the possibility still exists that through a combination of motor cooperation 
and short-distance processivity, myosin IIA could direct the transport of organelles for 
secretion, as has been described in the above studies.  Instances can be imagined in 
which the bulk of the transport has been performed by microtubule motors, and only brief 
transport is needed across actin filaments.  In these cases, myosin IIA may be perfectly 
suitable for this role. 
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MYH9-related disease 
 Mutations in the gene encoding the nonmuscle myosin IIA heavy chain, MYH9, 
cause an autosomal dominant platelet disorder now categorized as MYH9-related 
disease (MYH9-RD).  The disease was first described by Dr. Richard May in 1909 and 
Dr. Robert Hegglin in 1945, and was therefore initially termed May-Hegglin Anomaly 
(Hegglin, 1945; Saito and Kunishima, 2008).  The disorder was first characterized by 
giant platelets, thrombocytopenia, and leukocyte inclusions, also known as Döhle bodies 
(Hegglin, 1945; May, 1909).  Additional disorders were later described which were also 
due to MYH9 mutation, including Sebastian, Fechtner, and Epstein syndromes (Seri et 
al., 2003).  The confusion in nomenclature arose from the fact that in addition to the 
hematological symptoms above, certain MYH9 mutations can also cause variable non-
hematologic complications, including glomerulonephritis, sensorineural deafness, and 
presenile cataracts ((Heath et al., 2001; Seri et al., 2003); reviewed in (Savoia and 
Balduini, 1993)).  As genomic sequencing became standard for diagnosis, all of the 
disorders arising from mutations in MYH9 were grouped together as MYH9-RD.  The 
platelet disorders evident in this disease arise from the role of myosin IIA in regulating 
the migration and development of megakaryocytes (Chen et al., 2007; Eckly et al., 2009; 
Leon et al., 2007; Pecci et al., 2009); mutant myosin molecules are unable to properly 
regulate the production of proplatelets, resulting in macrothrombocytopenia (low 
numbers of abnormally large platelets).  While the reasons for the renal disease present 
in some patients is less clear, myosin IIA is important for maintaining podocyte structure 
and contractility, and therefore mutations in MYH9 may alter the filtration function of the 
glomerulus (Arrondel et al., 2002; Ghiggeri et al., 2003; Sekine et al., 2010). The 
mechanisms behind deafness and cataracts in MYH9-RD are, as of yet, poorly 
understood. 
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 Although some controversy still exists about whether there is a correlation between 
the position of the mutation and the symptoms of the disorder, there is now substantial 
support for a genotype-phenotype correlation (Dong et al., 2005; Franke et al., 2005; 
Kunishima et al., 2001b; Pecci et al., 2008).  In particular, patients with mutations in the 
head domain of myosin IIA are more likely to have severe macrothrombocytopenia, 
nephritis, and deafness, while patients with mutations in the rod and tailpiece typically 
have milder thrombocytopenia and do not exhibit non-hematological symptoms (Pecci et 
al., 2008).  Especially severe disease is seen in patients with mutations of Arg702, who 
often present with deafness early in life and can progress to end-stage renal failure 
during mid-life (Kunishima et al., 2007; Sekine et al., 2010). 
 While no immunodeficiency has been described in patients with MYH9-RD, myosin 
IIA is the primary myosin II isoform expressed in hematopoietic cells (Marigo et al., 2004; 
Maupin et al., 1994), and therefore mutations in MYH9 could have a greater effect on 
blood cells than on other systems. 
Requirement for myosin IIA function in NK cell cytotoxicity 
 Recent work in human NK cells has demonstrated a role for myosin IIA in NK cell 
cytotoxicity (Andzelm et al., 2007; Krzewski et al., 2006).  In primary human NK cells and 
human NK cell lines treated with the myosin II inhibitor blebbistatin or siRNA against 
myosin IIA (but not myosin IIB), cytotoxicity was significantly decreased (Andzelm et al., 
2007).  Although NK cells without myosin IIA function were capable of conjugating with 
target cells, polymerizing actin at the IS, and polarizing activation receptors, the MTOC, 
and lytic granules to the IS, they were unable to degranulate (Andzelm et al., 2007). 
Myosin IIA has also been shown to exist in a complex with actin and the actin-
remodeling proteins WIP and WASp at the IS in activated, but not inhibited, NK cells 
(Krzewski et al., 2006).  While this complex may be important for activation signaling, the 
polarization of activation receptors and polymerization of actin at the IS are intact in NK 
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cells following myosin inhibition (Andzelm et al., 2007), suggesting that myosin IIA may 
have an alternative role in NK cell cytotoxicity.  Examining the role of myosin IIA is the 
goal of this thesis. 
Thesis objectives 
The overall objective of this thesis was to examine the role of myosin IIA in NK cell 
degranulation and cytotoxicity, as well as the regulation of myosin IIA in this process.  I 
hypothesized that myosin IIA associates directly with NK cell lytic granules, mediating 
their transport across F-actin at the IS to enable degranulation.  As shown in Chapter 2, 
we have found that myosin IIA is associated with NK cell lytic granules, and that the 
motor function of myosin IIA is required for the ability of lytic granules to interact with F-
actin.  The myosin IIA nonhelical tailpiece was identified as critical to the ability of 
myosin to mediate the interaction of lytic granules with F-actin as well.  In Chapter 3, we 
examine the role of the tailpiece in regulating myosin IIA function on lytic granules.  We 
have found that there is a unique requirement for the head and tail regions of myosin IIA 
in NK cell cytotoxicity, and that the rod domain is less required for the function of myosin 
on lytic granules.  Furthermore, constitutive phosphorylation of Ser1943 in the nonhelical 
tailpiece of myosin IIA regulates the ability of myosin to interact productively with lytic 
granules.  Therefore, the tailpiece of myosin IIA is critical for granule transport across 
actin for NK cell cytotoxicity due to the requirement for this phosphorylation site in 
mediating the interaction of myosin IIA with lytic granules.  Finally, in Chapter 4, I 
examine the impact of these findings and discuss areas of future research. 
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Chapter 2: Myosin IIA associates with NK cell lytic granules to 
enable their interaction with F-actin2 
Summary 
 NK cell cytotoxicity requires the formation of an actin-rich immunological synapse 
(IS) with a target cell and the polarization of perforin-containing lytic granules toward the 
IS.  Following the polarization of lytic granules, they traverse through the actin-rich IS to 
join the NK cell membrane in order for directed secretion of their contents to occur.  We 
examined the role of myosin IIA as a candidate for facilitating this pre-final step in lytic 
NK cell IS function.  Lytic granules in and derived from a human NK cell line, or ex vivo 
human NK cells, were constitutively associated with myosin IIA. When isolated using 
density gradients, myosin IIA-associated NK cell lytic granules directly bound to F-actin 
and the interaction was sensitive to the presence of ATP under conditions of flow.  In NK 
cells from patients with a truncation mutation in myosin IIA, NK cell cytotoxicity, lytic 
granule penetration into F-actin at the IS, and interaction of isolated granules with F-
actin were all decreased.  Similarly, inhibition of myosin function also diminished the 
penetration of lytic granules into F-actin at the IS, as well as the final approach of lytic 
granules to and their dynamics at the IS.  Thus, NK cell lytic granule-associated myosin 
IIA enables their interaction with actin and final transit through the actin-rich IS to the 
synaptic membrane, and can be defective in the context of naturally occurring human 
myosin IIA mutation. 
                                                        
2
 A version of this chapter has been published as: 
 
Sanborn KB, Rak GD, Maru SY, Demers K, Difeo A, Martignetti JA, Betts MR, Favier R, Banerjee 
PP, Orange JS. 
Myosin IIA associates with NK cell lytic granules to enable their interaction with F-actin and 
function at the immunological synapse. 
The Journal of Immunology.  June 2009; Vol. 182 pp.6969-84. 
Copyright 2009.  The American Association of Immunologists, Inc. 
 
27
Introduction 
 NK cells are lymphocytes of the innate immune system which are important for 
defense against cancer and viral infection (reviewed in (Vivier et al., 2008)).  NK cells 
directly kill transformed and infected cells, and also provide costimulation and produce 
cytokines to enhance immunity.  Following NK cell conjugation with a target cell, an IS 
forms at the contact site.  The IS represents an arrangement of molecules that changes 
over time to enable NK cell functions (Banerjee, 2008; Davis and Dustin, 2004; Orange, 
2008).  During NK cell cytotoxicity, the IS matures to consist of a peripheral ring of F-
actin and adhesion molecules surrounding a secretory domain containing lytic granules 
(Stinchcombe et al., 2006).  Upon initial adhesion to target cells, NK cell activation 
causes polarization of the NK cell secretory machinery toward the target cell.  Lytic 
granules traffic to the IS via microtubules, and exocytosis of their contents, including 
granzymes and perforin (Peters et al., 1991), at the plasma membrane is required for 
cytotoxicity (Banerjee et al., 2007; Chen et al., 2006; Kopcow et al., 2005; Kupfer et al., 
1991; Orange et al., 2003).  While discrete steps in cytotoxicity have been identified 
following the movement of lytic granules to the IS with the MTOC, these primarily involve 
docking and fusion with the cell membrane (Bryceson et al., 2007; Feldmann et al., 
2003; Menager et al., 2007).  The F-actin cortex at the IS is dense, however, and 
although the lytic granules may come very close to the membrane via microtubules, the 
actin accumulated at the IS and bordering a secretory domain may nonetheless present 
an obstacle to lytic granules reaching the membrane.  Therefore, transit through the F-
actin-rich cell cortex may present an additional requirement for granule release prior to 
membrane fusion. 
 Myosin superfamily members have been defined as important facilitators of 
immunological function (Andzelm et al., 2007; Jacobelli et al., 2004; Ludowyke et al., 
2006).  Myosins are ATP-dependent motors which generate force and movement along 
 
28
actin filaments and can facilitate cell motility and migration (Deng et al., 1999; 
Geisbrecht and Montell, 2002; Jacobelli et al., 2004; Lee et al., 2004).  Nonmuscle 
myosin IIA, however, may have an additional role in NK cells, as it is present in a 
heterogeneous protein complex formed in NK cells upon their conjugation with 
susceptible target cells (Krzewski et al., 2006).  Myosin IIA is a hexameric protein 
consisting of two heavy chains, two regulatory light chains, and two essential light chains 
(reviewed in (Sellers, 2000)).  The N-terminal portion of the protein binds to actin and is 
important for ATP-dependent motor function, while the C-terminal portion is involved in 
filament formation and cargo binding (Cross and Vandekerckhove, 1986; Eddinger and 
Meer, 2007; Ikebe et al., 2001; Nyitray et al., 1983; Sinard et al., 1990).  Recently, a 
requirement for myosin IIA in NK cell degranulation was defined (Andzelm et al., 2007).  
Interference with myosin IIA function using the specific myosin II inhibitor blebbistatin 
(Straight et al., 2003) or the myosin light chain kinase inhibitor ML-9 (Saitoh et al., 1987), 
or myosin IIA small inhibitory RNA, decreased NK cell cytotoxic activity and exocytosis 
of lytic granule contents, but did not alter effector-target conjugation or NK cell IS 
formation (Andzelm et al., 2007). While myosin IIA has been implicated in the overall 
process of NK cell cytotoxicity (Andzelm et al., 2007), it is unclear how it enables lytic 
granule exocytosis. 
 Mutations in the heavy chain of myosin IIA, MYH9, cause several human 
disorders, including May-Hegglin anomaly (Heath et al., 2001; Kelley et al., 2000; Seri et 
al., 2000), characterized by macrothrombocytopenia and leukocyte inclusions.  
Additional variable somatic abnormalities can occur depending upon the specific MYH9 
mutation, however, previous studies of patients with these disorders have not pursued or 
identified immunological deficiencies.  Here, we define a deficiency of NK cell 
cytotoxicity in four patients with May-Hegglin anomaly resulting from a C-terminal 
truncation of MYH9 at position 1933 and have defined a potential mechanism by which 
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myosin IIA enables NK cell lytic granule exocytosis.  We demonstrate that myosin IIA 
constitutively interacts with NK cell lytic granules and is required for the functional 
interaction of lytic granules with F-actin as well as their final approach to the synaptic 
membrane. 
Results 
Human NK cells with a myosin IIA 1933x mutation have reduced cytotoxicity and 
lytic granule entry into F-actin at the IS 
 Inhibition of myosin IIA with blebbistatin or ML-9, or reduction of its expression using 
siRNA was previously shown to block NK cell cytotoxicity but not lytic granule 
polarization to the IS (Andzelm et al., 2007). Thus, we wanted to determine the role of 
myosin IIA in enabling granule release following lytic granule polarization.  To evaluate 
an endogenous role for myosin IIA in human NK cells with a link to disease, we 
assessed NK cell function in four May-Hegglin anomaly patients heterozygous for a 
C5797T mutation in MYH9.  This mutation introduces a stop codon leading to C-terminal 
truncation of the myosin IIA heavy chain at position 1933 (1933x (Kelley et al., 2000; 
Seri et al., 2000)). PBMCs from all four patients demonstrated significantly reduced 
cytotoxic activity against K562 target cells when compared to control donors (Figure 
2.1A,B).  To determine that the reduction in cytotoxicity was not transient, one of the four 
patients (patient 1) was evaluated longitudinally. In four independent assessments over 
a period of twenty months, the mean cytotoxicity mediated by patient PBMCs was 
reduced (data not shown).  To ensure that the reduced cytotoxicity was not a feature of 
other cells present in PBMC preparations, and to control for potential variability in the 
percentage of NK cells, NK cells from three patients and controls were enriched by 
negative selection and immediately evaluated in a cytotoxicity assay.  The cytotoxic 
activity of patient ex vivo NK (eNK) cells against K562 target cells was still reduced 
compared to control eNK cells (Figure 2.1B,C).  Since myosin IIA was previously shown  
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to be needed for NK cell degranulation as determined by CD107a upregulation (Andzelm 
et al., 2007), we wanted to determine if the decreased cytotoxicity in patient NK cells 
was due to a similar blockade.  After incubation with K562 target cells, CD107a was 
upregulated on control donor NK cells, but not on those from a patient (Figure 2.1D).  
Thus, both cytotoxicity and degranulation are defective in patients with a myosin IIA 
truncation, similar to blebbistatin or MYH9 siRNA-treated NK cells (Andzelm et al., 
2007).  
 
Figure 2.1.  Effect of myosin IIA 1933x mutation on cytotoxicity and perforin 
localization at the IS.   
(A) Cytotoxicity of control donor (blue) and myosin IIA 1933x patient (red) PBMCs against 
K562 target cells. Mean ±SD specific K562 
51
Cr-release from 3 separate control donors and 
patients is shown.  Individual experiments were performed in triplicate and averages of these 
were used to calculate means of the patients or controls ± SD. (B) Mean K562 lytic units ±SD 
of PBMCs and eNK cells from four control donors (black) and myosin IIA 1933x patients 
(gray). Patient and control means were compared using the exact Wilcoxon-Mann-Whitney 
test: **p=0.014 for PBMCs and *p=0.05 for eNK cells. (C) Cytotoxicity of control donor (blue) 
and myosin IIA 1933x patient (red) eNK cells against K562 target cells.  Mean ±SD specific 
51
Cr-release from three separate control donors and patients is shown.  (D) Flow cytometric 
analysis depicting CD107a exposure in CD3
-
CD4
-
CD56
+
 cells from control donor and myosin 
IIA 1933x patient PBMC populations mixed with DMSO or K562 cells.  Flow cytometry was 
performed with the assistance of Korey Demers. 
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Figure 2.2.  IS formation in NK cells with 1933x mutant myosin.   
Confocal fluorescent micrographs of control donor (A,F), myosin IIA 1933X patient 1 and 3 
(B,G), and blebbistatin-treated control (C) eNK cells conjugated with K562 target cells. 
Differential interference contrast (DIC), actin (blue), wild-type myosin IIA (red), perforin 
(green), and overlays are shown.  Scale bar = 5 µm.  Anti-myosin IIA antibodies were utilized 
that recognize wild-type (A-C) or both mutant and wild-type forms (F-G). (D,H) Mean volume 
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 To examine the mechanism underlying defective cytotoxicity in 1933x patient NK 
cells, we evaluated the localization of perforin, which is contained in lytic granules, 
relative to F-actin and myosin IIA at the IS in patient eNK cells.  Control donor and 1933x 
patient eNK cells were conjugated to K562 target cells, fixed, and evaluated using 
confocal microscopy.  In eNK cells with perforin polarized toward the IS, volumes of 
perforin, actin, and myosin IIA fluorescence were identified.  In control eNK cells, there 
was extensive colocalization between volumes of perforin and F-actin (Figure 2.2A,F 
and Video 1A), suggesting the penetration of lytic granules into accumulated F-actin at 
the IS.  In contrast, in 1933x eNK cells (Figure 2.2B,G and Video 1B) and blebbistatin-
treated eNK cells (Figure 2.2C and Video 1C), perforin was polarized toward the IS 
(quantified in Figure 2.3A), but there was substantially reduced colocalization between 
volumes of perforin and F-actin at the IS compared to control (Figure 2.2E,I).  This 
suggests that myosin-IIA function was required for lytic granule penetration into F-actin 
accumulated at the IS. 
 To begin to understand the role of myosin IIA in granule penetration into F-actin at 
the IS, we evaluated myosin IIA localization in eNK cells using one of two different 
antibodies. The first detected only wild-type myosin IIA, while the second detected both 
truncated and wild-type forms. In control eNK cells, there was extensive colocalization 
between perforin and myosin IIA (Figure 2.2A,D,E,F,H,I and Video 1D).  In patient eNK 
cells, colocalization between perforin and wild-type myosin IIA was reduced (Figure 
2.2B,D,E; 6C,D; and Video 1E), but when total myosin IIA was considered, the 
±SD occupied by actin (A), perforin (P), myosin IIA (M), or a combination is shown for control 
(black), myosin IIA 1933X patient (gray), and blebbistatin-treated (white, D only) eNK cells 
conjugated with K562 cells.  (E, I) Mean percent colocalization ±SD among the fluorescent 
volumes in control (black), myosin IIA 1933X patient (gray), and blebbistatin-treated (white, E 
only) eNK cells conjugated with K562 cells. The percentage of myosin IIA colocalized with 
perforin (M/P), perforin with myosin (P/M), perforin with actin (P/A), actin with perforin (A/P), 
and actin with myosin and perforin (A/M/P) are shown.  ≥10 cells per condition are 
represented. Imaging and analysis were performed with the assistance of Pinaki Banerjee. 
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colocalization of perforin with myosin IIA was similar to control (Figure 2.2G,H,I). This 
suggests that although a normal amount of myosin IIA colocalized with perforin in patient 
NK cells, its function was reduced by the inclusion of the mutant form.  In blebbistatin-
treated eNK cells, however, the colocalization between perforin and myosin IIA was 
slightly reduced compared to control (Figure 2.2C,D,E and Video 1F).  Differences were 
not a feature of protein present per unit volume, as the total mean intensity of fluorescent 
regions was similar between the different eNK evaluated (Figure 2.3B).  The quantity of 
perforin and actin in cells and the quantity of F-actin accumulated at the IS was also 
similar between control, 1933x, and blebbistatin-treated cells (Figure 2.3A-B,G), 
suggesting that defective myosin IIA was not affecting these parameters. Thus, although 
actin accumulated at and perforin polarized toward the IS, the colocalization between 
perforin and F-actin in 1933x and blebbistatin-treated eNK cells was reduced relative to 
control.  This suggests decreased penetration of lytic granules into the F-actin cortex at 
the IS in these cells and implies a role for myosin IIA in facilitating lytic granule 
interaction with F-actin after they are polarized to the IS. 
Myosin IIA is not required for IFN-γ secretion 
 Because myosin IIA was previously demonstrated to be necessary for exocytosis of 
lytic granule contents (Andzelm et al., 2007), we wanted to determine whether it is a 
general requirement for all types of secretion in NK cells.  Thus, we measured IFN-
γ secretion, which is a differentially regulated process from degranulation in NK cells 
(Vahlne et al., 2008).  We initially used YTS NK cells because they require myosin IIA for 
cytotoxicity and lytic granule release, similar to eNK cells (Andzelm et al., 2007).  YTS 
cells were treated with vehicle control or blebbistatin and incubated in the presence or 
absence of 721.221 target cells.  The secretion of IFN-γ into the supernatant was 
determined by ELISA after 0, 4, or 22 hours of incubation.  In the absence of 721.221 
cells, there was minimal IFN-γ in both vehicle- and blebbistatin-treated cell cultures.  In  
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Figure 2.3. Analysis of function and protein localization in NK cells from myosin 
IIA 1933x patients 1 & 3. 
(A) Mean distance ±SD of perforin centroid to the immunological synapse is shown for the 
conjugates analyzed in Figure 2.2D-E. (B) Mean voxel intensity ±SD of actin (A), perforin (P), 
wild-type myosin IIA (M), or a combination is shown for the conjugates analyzed in Figure 
2.2D-E. (C) Mean percent colocalization ±SD among the fluorescent volumes in control (black) 
and myosin IIA 1933X patient 3 (gray) eNK cells conjugated with K562 cells.  The percentage 
of wild-type myosin colocalized with perforin (M/P), perforin with myosin (P/M), perforin with 
actin (P/A), actin with perforin (A/P), and actin with myosin and perforin (A/M/P) are shown. 
(D) Mean volume ±SD occupied by actin (A), perforin (P), wild-type myosin IIA (M), or a 
combination is shown for control (black) and myosin IIA 1933X patient 3 (gray) eNK cells 
conjugated with K562 cells. For (C-D), 10 cells are represented. (E) Flow cytometric analysis 
of mean ±SD perforin content of blebbistatin-treated and control eNK cells from 3 independent 
donors.  (F) Mean volume ±SD of perforin fluorescence is shown for the conjugates analyzed 
in Figure 2.2D-E.  (G) Mean F-actin accumulation ±SD at the IS (area x intensity of F-actin 
fluorescence) is shown for the conjugates described in Figure 2.2D-E.   Analysis was 
performed with the assistance of Pinaki Banerjee. 
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the presence of 721.221 cells, however, IFN-γ secretion was augmented after 4 hours 
and increased further after 24 hours of incubation.  The amount of IFN-γ secreted by 
blebbistatin-treated cells was similar to that secreted by vehicle-treated cells (Figure 
2.4A).  This result was extended to control donor eNK cells allowed to conjugate with 
721.221 cells, where there was also no inhibition of IFN-γ secretion observed in 
blebbistatin-treated relative to vehicle-treated cells (Figure 2.4B).  This demonstrates 
that myosin IIA is not required for cytokine secretion, and that it is not a generalized 
requirement for secretory activity in NK cells. 
Myosin IIA and perforin colocalize in NK cells before and throughout IS formation 
 Because the requirement for myosin IIA in secretion appears to be specific to NK cell 
lytic granule contents, we wanted to more thoroughly evaluate the localization of myosin 
IIA relative to lytic granules in NK cells.  YTS cells expressing a myosin IIA-GFP fusion 
protein (YTS-MyoIIA-GFP) were generated and compared to YTS cells expressing GFP 
alone using fixed and live cell confocal microscopy.  Both of these cell lines, as well as  
     
 
Figure 2.4. Effect of inhibition of myosin IIA on NK cell IFN-γ secretion.   
(A) YTS cells incubated with DMSO vehicle control or blebbistatin for 30 min and then 
incubated in the presence or absence of 721.221 target cells at a 2:1 effector to target cell 
ratio for 0h (white), 4h (gray), or 22h (black). IFN-γ secreted into supernatant was measured 
by ELISA.  Values shown are the mean ±SD of six independent experiments, each performed 
on a separate date.  (B) IFN-γ secretion by vehicle- or blebbistatin-treated control donor eNK 
cells incubated in the presence of 721.221 target cells at a 2:1 effector to target ratio for 22h.  
In each experiment, the IFN-γ secreted by blebbistatin-treated eNK cells was normalized to 
the control (which is shown as 100%) and the values shown are the mean ±SD of three 
independent experiments, each performed on a separate date. ELISA was performed with the 
assistance of Saumya Maru. 
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parental YTS cells, expressed similar levels of endogenous myosin IIA (Figure 2.5A), 
however, YTS-MyoIIA-GFP cells expressed the additional myosin IIA-GFP fusion 
protein.  The overexpression of myosin IIA in these cells did not alter their cytotoxic 
function, as measured in 51Cr-release assays (Figure 2.5B,C). 
 Using these cells, we first determined the localization of myosin IIA and perforin 
throughout their volumes when conjugated to K562 cells made susceptible to YTS cell 
cytotoxicity by stable expression of CD86 (KT86 (Banerjee et al., 2007)).  As myosin IIA 
is abundant in NK cells, an analysis algorithm was used with an intensity threshold to 
include only the most intense fluorescent signal for myosin IIA, GFP, and perforin.  
Myosin IIA was cytoplasmic but demonstrated variations in intensity, as identified using 
anti-myosin IIA antibody, in fixed conjugates from all three cell lines (Figure 2.6A-C).  In 
YTS-GFP cells, GFP was localized throughout the cells, while in YTS-MyoIIA-GFP cells, 
           
Figure 2.5.  Expression and function of myosin IIA and perforin in unconjugated 
NK cells.   
(A) Western blot of whole cell lysate from YTS, YTS-GFP, and YTS-Myosin IIA-GFP cells 
depicting myosin IIA (blue) and GFP (red).  (B-C) Mean cytotoxicity ±SD of YTS, YTS-GFP, 
and YTS-Myosin IIA-GFP cell lines with 721.221 (B) and KT86 (C) target cells from three 
independent experiments.  The mean of three replicates within each experiment was used to 
generate the value for a given experiment. 
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the GFP resembled myosin IIA localization (Figure 2.6B-C), and the mean percent 
colocalization between GFP and myosin IIA in YTS-MyoIIA-GFP cells was higher than in 
YTS-GFP cells (Figure 2.7A).  Thus, myosin IIA-GFP fusion protein but not GFP alone 
recapitulated the localization of endogenous myosin IIA. 
 In all cell lines, myosin IIA colocalized with lytic granules, as 4-14% of the myosin IIA 
volume colocalized with perforin, and 39-65% of perforin volume colocalized with myosin 
IIA (Figure 2.7B).  Thus, a small pool of myosin IIA localized in lytic granule regions, but 
a large proportion of lytic granule regions colocalized with myosin IIA. A similar 
colocalization between perforin and myosin IIA-GFP fusion protein, but not GFP alone, 
was identified in YTS-MyoIIA-GFP and YTS-GFP cells, respectively (Figure 2.7A).  
Thus, the localization of the myosin IIA-GFP fusion protein to lytic granule regions was 
specific. 
 We next wanted to determine if the colocalization between myosin IIA and lytic 
granules changed during NK cell activation and IS formation in living cells.  YTS-MyoIIA-
GFP or YTS-GFP cells were loaded with Lysotracker Red dye to visualize the lytic 
granules, added to environmental chambers containing KT86 target cells and imaged 
every 15 seconds.  After conjugation, the lytic granules in NK cells began to polarize 
toward the target cell (Figure 2.6D,E).  During this time, in YTS-MyoIIA-GFP cells, a 
portion of the myosin IIA-GFP in the cell remained with the lytic granules and polarized 
along with them toward the IS (Figure 2.6D and Video 2). Although lytic granules still 
polarized to the IS in YTS-GFP cells, the GFP was not increased in the region of the lytic 
granules (Figure 2.6E and Video 3).  This dynamic localization of myosin IIA-GFP, but 
not GFP alone, with lytic granule regions was best visualized using a GFP intensity 
pseudocolor scale (Figure 2.6D,E bottom and Videos 2,3 bottom).  To quantify this 
colocalization, multiple conjugated and unconjugated YTS-MyoIIA-GFP cells were 
compared, and only the most intense myosin IIA-GFP fluorescence was measured (>1.5  
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Figure 2.6. Myosin IIA colocalization with lytic granules.  
Colocalization is measured in fixed (A-C) and live (D-I) NK cells.  (A-C) Cytolytic conjugates 
between YTS (A) YTS-GFP (B), or YTS-Myosin IIA-GFP (C) cells and a KT86 target cell.  
Differential interference contrast (DIC) and confocal fluorescent images for myosin IIA (blue), 
GFP (green), GFP intensity (rainbow), perforin (red), and overlays of fluorescence are shown.  
Inset panels in lower left corner show an enlargement of the area containing lytic granules. (D-
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SD above the mean fluorescence intensity). The colocalization of Lysotracker Red with 
myosin IIA-GFP was similar in unconjugated (mean = 65±4%) and conjugated (mean = 
77±10) cells with no specific trend toward an increase or decrease in colocalization 
(Figure 2.6F).  A similar consistent colocalization between cellular myosin IIA-GFP and 
Lysotracker Red was identified (12±1 in unconjugated and 17±4 in conjugated cells) 
(Figure 2.6G).  Furthermore, the intensity of myosin IIA-GFP within Lysotracker Red 
regions remained constant after conjugation (Figure 2.6H), suggesting that recruitment 
of myosin IIA-GFP to lytic granules was unlikely. The colocalization between Lysotracker 
Red and GFP in YTS-GFP cells was consistently lower than in YTS MyoIIA-GFP cells 
(Figure 2.6I), thus demonstrating that the presence of myosin IIA in the GFP fusion 
enabled its preferential and consistent colocalization with lytic granules. 
Myosin IIA is associated with NK cell lytic granules 
 To biochemically determine if myosin IIA interacts with lytic granules, granules were 
isolated from NK cells by density gradient separation and collected in seven equal 
volume fractions.   Myosin IIA was identified in the lytic granule preparation by Western 
blot, and co-migrated with perforin, granzyme B, and LAMP-1 (Figure 2.8A).  All four 
proteins were enriched in fractions 4-6 compared to the post nuclear lysate.  These  
E) Live cell confocal images of Lysotracker Red-loaded YTS-MyoIIA-GFP (D) or YTS-GFP (E) 
cells conjugated with KT86 target cells.  The DIC image taken at 0 min is shown (left).  Top 
panels show an overlay of Myosin IIA-GFP (YTS-MyoIIA-GFP) or GFP (YTS-GFP) (green) 
with Lysotracker Red (red); bottom panels use a pseudocolor scale to show intensity of GFP 
only (Lysotracker Red fluorescence was removed prior to applying color scale). In all images, 
an intensity threshold has been applied to the fluorescent signal so that only 3 SD above the 
mean intensity for each fluorophore is shown.  Scale bars = 10 µm.  (F-G) Mean percent ±SD 
Lysotracker Red fluorescent area colocalized with myosin IIA-GFP fluorescent area (F) and 
mean percent ±SD myosin IIA-GFP colocalized with Lysotracker Red (G) in YTS-Myosin IIA-
GFP cells over time after conjugation with KT86 target cells (black lines).  Red lines indicate 
percent colocalized fluorescent areas ±SD in unconjugated cells over time.  (H) Mean GFP 
fluorescence intensity ±SD over time at the colocalized area between myosin IIA-GFP and 
Lysotracker Red after conjugation to target cells.  (I) Mean percent ±SD Lysotracker Red 
fluorescent area colocalized with GFP fluorescent area of YTS-GFP cells over time after 
conjugation with KT86 target cells (black line).  Red line indicates percent colocalized area 
±SD in unconjugated cells. All graphs represent live cell image sequences of ≥8 conjugates.  
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fractions contained 80-90% of the total protein in the granule fractions.  There was a 
paucity of actin in lytic granule fractions, demonstrating the general lack of cellular 
contamination (Figure 2.8A). Myosin IIA-containing lytic granule fractions possessed 
granzyme A activity (Figure 2.8B) and were able to kill 51Cr-labeled KT86 and 721.221 
target cells (Figure 2.8C,D).  The presence of myosin IIA in these fractions was verified 
by mass spectrometry, as were perforin and granzyme B (Figure 2.8E and data not 
shown). This association was also observed by confocal microscopy. Lytic granules 
isolated from YTS-MyoIIA-GFP cells and loaded with Lysotracker Red demonstrated red 
and green fluorescence in granule-sized organelles (Figure 2.8F). The association 
between myosin IIA and lytic granules did not change after target cell conjugation, as 
granules prepared from unconjugated and conjugated YTS cells had a similar amount of 
myosin IIA when compared to the amount of granzyme B by Western blot analysis 
(Figure 2.9). 
 To ensure that our results were not specific to YTS cells and to determine if 1933x 
myosin IIA affected interaction with lytic granules, granules were isolated from control 
donor and patient culture-propagated NK cells.  In both normal donor and patient lytic 
        
Figure 2.7.  Evaluation of fluorescence in fixed cell conjugates.   
(A) The percent colocalization among fluorescent volumes in ≥ 8 YTS-GFP (gray) and YTS-
Myosin IIA-GFP (black) NK cells conjugated to KT86 target cells was calculated to 
demonstrate the percentage of myosin IIA volume colocalized with GFP (M/G), GFP 
colocalized with myosin IIA (G/M), perforin colocalized with GFP (P/G), and GFP colocalized 
with perforin (G/P), ±SD. (B) The percent colocalization among fluorescent volumes in ≥ 8 
YTS (white), YTS-GFP (gray), and YTS-Myosin IIA-GFP (black) NK cells conjugated to KT86 
target cells was calculated to demonstrate the percentage of myosin IIA volume colocalized 
with perforin (M/P) and perforin colocalized with myosin IIA (P/M), ±SD.  
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granules, myosin IIA co-migrated with granzyme B (Figure 2.8G,I) and with granzyme A 
activity (Figure 2.8H,J), implying that myosin IIA associates with human NK cell lytic 
granules.  To determine if the mutant myosin IIA was capable of interacting with lytic 
granules, we utilized the two different myosin IIA antibodies used in Figure 2.2.  If only 
wild-type myosin IIA were associated with lytic granules, the densitometric ratio of bands 
detected with the two different antibodies should approach 1.0.  As expected, this ratio 
approximated 1 in control donor lytic granules (Figure 2.8G), but did not in patient lytic 
granules (Figure 2.8I). Thus, both wild type and mutant myosin IIA was associated with 
lytic granules from patient NK cells. The densitometric ratio of total myosin IIA to 
granzyme B was similar in patient and control lytic granules, however, and therefore the 
total quantity of myosin IIA was not reduced in patient granules compared to control 
(Figure 2.8G,I).  
 To gain greater insight into how lytic granule-associated myosin IIA could contribute 
to function, we next attempted to determine the precise localization of myosin IIA on NK 
cell lytic granules.  We first performed immuno-electron microscopy on intact 
unconjugated control donor eNK cells as well as isolated YTS cell lytic granules.  In 
unconjugated eNK cells, myosin IIA was identified on the periphery of lytic granules 
(Figure 2.10A).  This was confirmed by EM analysis of isolated lytic granules, which 
were decorated with anti-myosin IIA antibody (Figure 2.10B), but not secondary antibody 
alone (Figure 2.10C).  As an additional approach, isolated lytic granules were surface 
biotinylated, followed by precipitation of granule surface proteins with streptavidin-
agarose.  Here, myosin IIA was identified in the precipitate from biotinylated lytic 
granules, but not unlabeled lytic granules (Figure 2.10D).  Overall, these data suggest 
that myosin IIA is associated with lytic granules in NK cells and is located on their 
surface and not in the core of these organelles.  In this location, it may be poised to  
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Figure 2.8. Evaluation of myosin IIA in isolated NK cell lytic granules.   
Fractions from density gradient separation of lytic granules from YTS (A-E), YTS-Myosin IIA-
GFP (F), control NK (G-H), and 1933X NK (I-J) cells.  (A, G, I) Myosin IIA, granzyme B, 
LAMP-1, perforin, and actin Western blot of density gradient fractions, from least (1) to most 
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facilitate the interaction of lytic granules with actin and their penetration into the F-actin-
rich IS. 
Myosin IIA-associated lytic granules can bind F-actin 
 To demonstrate a potential function of lytic granule-associated myosin IIA, we 
examined the ability of isolated NK cell lytic granules to bind F-actin using a 
centrifugation-based assay.  Lytic granules were incubated in the presence of F-actin 
and then subjected to centrifugation at a speed which pellets lytic granules, but not F-
actin alone.  Addition of YTS cell lytic granules to F-actin resulted in the presence of F-
actin in the lytic granule pellet and reduced F-actin in the residual supernatant (Figure 
2.11A,B).  The percent of F-actin pelleted by the lytic granules was similar to that 
obtained in the pellet after addition of the actin bundling protein α-actinin, which was 
used as a positive control to aggregate F-actin. Transmission EM of the pellet from lytic 
granules added to F-actin demonstrated filamentous material associated with the lytic 
granules (Figure 2.11E); the granule pellet alone without added F-actin did not (Figure 
2.11F).  Similarly, Western blot of the granule pellet from the control portion of this 
assay, in which F-actin was not added, did not demonstrate the presence of actin 
(Figure 2.11A).  Thus, the presence of actin in the pellet after addition of exogenous F-
actin defines a specific interaction between lytic granules and F-actin.   
dense (7) as well as the post-nuclear lysate (PNL) and crude lysosomal fraction (CLF) generated 
in preparing the starting material for the density gradient. In (G, I), anti-myosin IIA antibodies with 
specificities for both wild type and 1933x myosin IIA (top), or only wild-type myosin IIA (middle).  
Densitometric ratios of total to wild-type epitope recognizing antibody signal, as well as total 
myosin IIA to granzyme B, are shown below the Western blots. (B, H, J) Serine esterase activity 
of YTS (B), control NK (H), and 1933x NK cell (J) density gradient fractions. (C-D) Cytotoxicity of 
KT86 (C) and 721.221 (D) target cells mediated by YTS density gradient fractions.  (E) Mass 
spectrometric analysis of peptides identified in a density gradient fraction from YTS cells enriched 
in myosin IIA and granzyme B, identifying MYH9 in the bands demonstrated in the Western blots.  
The diagram (left) depicts peptide coverage of MYH9, and the mass spectra (right) represent the 
most N-terminal and most C-terminal peptides identified.  (F) Confocal fluorescent images of 
isolated lytic granules from YTS-Myosin IIA-GFP cells (gradient fractions 5 and 6) loaded with 
Lysotracker Red.  Presumed lytic granules (arrows) demonstrated both Lysotracker (red) and 
myosin IIA-GFP (green) fluorescence.  Scale bar = 4 µm.  Mass spectrometry was performed with 
the assistance of the Stokes Protein Core Facility at Children’s Hospital of Philadelphia. 
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 To confirm that this property of NK cell lytic granules was not specific to YTS cells, 
and to evaluate the effect of 1933x myosin IIA, F-actin-binding assays with isolated lytic 
granules from control donor and patient NK cells were performed.  The addition of 
control, but not patient, NK cell lytic granules to F-actin resulted in actin in the lytic 
granule pellet and reduced actin in the residual supernatant (Figure 2.11C,D). Overall, 
while control donor NK cell lytic granules were able to associate with nearly the same 
amount of F-actin as the positive control (86±2% of the quantity removed from the 
supernatant by α-actinin determined by densitometry of actin bands), granules from 
1933x patient NK cells could only associate with less than half of the amount of F-actin 
as positive control (42±3% of α-actinin).  This demonstrates that normal human NK cell 
lytic granules can bind F-actin and suggests that 1933x myosin IIA reduced the ability of 
patient lytic granules to interact with F-actin.  This implies a specific role for lytic granule-
associated myosin IIA in F-actin binding. 
 To directly observe the binding of the isolated lytic granules to F-actin, we 
constructed microflow chambers coated with biotinylated BSA and streptavidin (BSA/SA, 
Figure 2.12), or BSA/SA and F-actin stabilized with biotinylated phalloidin (Figure 2.12), 
                                             
 
Figure 2.9. Biochemical analysis of myosin IIA accumulation in the lytic granule 
fraction (fraction 6) before and after physiologic YTS activation.  
Quantitative analysis of mean myosin IIA to granzyme B ratio ±SD from Western blots using 
three independent lytic granule preparations from YTS cells.  YTS cells and KT86 cells were 
either conjugated (black) or left unconjugated and lysed separately prior to lytic granule 
isolation (gray). 
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 to which lytic granules were added.  We initially studied lytic granules from YTS-MyoIIA-
GFP cells, which were visible by confocal fluorescence microscopy due to the presence 
of myosin IIA-GFP.  When suspended in a physiologic salt buffer and added to a 
BSA/SA-coated microflow chamber, the lytic granules did not adhere to the coated glass 
surface (Figure 2.13A,B and Video 4A).  When added to an F-actin-coated microflow 
chamber, however, the granules adhered to the chamber, despite continued flow of 
buffer (Figure 2.13A,B and Video 4B).  After lytic granules were stable in their position, 
buffer was changed from physiologic salt to high salt containing 5 mM ATP, which 
abrogates myosin II binding to F-actin by first causing myosin II detachment from actin 
through its ATP-dependent motor activity and then preventing rebinding through the 
presence of high salt (Yanagida et al., 1985).  Under these conditions, most granules no 
longer adhered to the microflow chamber (Figure 2.13A,B and Video 4C).  The granules 
did not begin to move through the chamber upon addition of high-salt buffer containing 
no ATP (data not shown), suggesting that the granules are released from F-actin by the  
 
 
Figure 2.10. Ultrastructural localization of myosin IIA in NK cells and isolated 
lytic granules.   
(A) Electron micrograph of an unconjugated eNK cell stained with rabbit anti-myosin IIA Ab 
followed by gold-conjugated anti-rabbit Ab.  LG = lytic granule.  Arrows indicate areas 
containing gold particles.  Scale bar = 500 nm.  (B) Electron micrograph of isolated lytic 
granules from YTS cells stained with rabbit anti-myosin IIA Ab followed by gold-conjugated 
anti-rabbit Ab. Arrows indicate areas containing gold particles.  Scale bar = 500 nm. (C) 
Electron micrograph of isolated lytic granules from YTS cells stained with gold-conjugated 
anti-rabbit Ab alone. Scale bar = 500 nm. Arrows indicate gold particles.  (D) Western blot of 
streptavidin-agarose immunoprecipitates from unlabeled lytic granules (No Bio) and surface-
biotinylated lytic granules (Bio), and whole cell lysate (WCL) from YTS cells.  Electron 
microscopy was performed with the assistance of Raymond Meade and Neelima Shah. 
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addition of ATP.  Granules that were pretreated with blebbistatin also failed to properly 
adhere to F-actin-coated chambers (Figure 2.13A), further implicating a specific role for 
myosin II. 
 To confirm that these properties of YTS-MyoIIA-GFP-derived lytic granules were 
relevant to primary human NK cells and to define the effect of 1933x myosin IIA, lytic 
granules prepared from culture-propagated control and patient eNK cells were loaded 
with Lysotracker Green and evaluated in the microflow chambers.  In F-actin-coated 
chambers with physiologic salt buffer, control, but not patient, granules adhered to the 
 
 
Figure 2.11.  Interaction between myosin IIA-associated lytic granules and F-actin.   
Lytic granules from an isolated fraction enriched in myosin IIA and granzyme B were prepared 
from YTS (A-B, E-F), control NK (C), and myosin IIA 1933x patient NK (D) and incubated for 
30 min in the presence or absence of F-actin.  After centrifugation at 18,000g, the pellet (P) 
and supernatant (S) were evaluated for actin and granzyme B by Western blot (A, C, D).   As 
a positive control, α-actinin was used to bundle the F-actin, causing it to pellet.  Pellet and 
supernatant from the assay were separated. (B) Percentage of actin in the pellet ±SD from 
three independent experiments, determined by densitometric analysis.  *= p<0.05 compared 
to buffer (negative control).  (E-F) Electron micrographs of lytic granule pellets.  The pellet 
obtained from the mixture of lytic granules and F-actin (E) was compared to the pellet of lytic 
granules alone (F).  Scale bar = 500 nm.  Electron microscopy was performed with the 
assistance of Raymond Meade. 
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coated glass surface similarly to the YTS-MyoIIA-GFP granules (Figure 2.13C,D and 
Videos 5A,6A).  Upon exposure to high-salt buffer containing ATP, granules from both 
control donor and patient eNK cells were not adherent to the F-actin-coated chamber 
(Figure 2.13C,D and Videos 5B,6B).  These results demonstrate a direct interaction 
between NK cell lytic granules and F-actin and suggest a critical role for intact myosin 
IIA function in this process. 
Myosin II function is necessary for lytic granule approach to the IS 
 Since we found that NK cell lytic granules adhere to F-actin, we wanted to determine 
if myosin IIA could facilitate granule movement through the F-actin dense cell cortex.  To 
test this, we used TIRF microscopy to image granules at the activated surface of YTS 
cells. We have previously shown that YTS cells polarize their lytic granules to and 
accumulate F-actin at anti-CD28-coated glass surfaces within 30 minutes (Banerjee et 
al., 2007).  Thus, Lysotracker Green-loaded YTS cells were adhered to anti-CD28-
coated environmental chambers for 25 minutes, and lytic granule polarization toward the 
contact site was determined using confocal fluorescent z-axis sectioning (Figure 2.14A).  
Cells with polarized lytic granules were then imaged in TIRF mode at a maximum 
acquisition rate for 30 seconds.  In control YTS cells, lytic granules were dynamically  
                       
Figure 2.12.  Actin-coated microflow chambers.   
TIRF images of microflow chambers coated with BSA and streptavidin (BSA/SA, left) and 
BSA/SA/Actin (right) for actin-binding assay in Figure 2.13.  Actin filaments are visualized 
using AlexaFluor 488-Phalloidin (light blue).  TIRF was performed with the assistance of 
Gregory Rak. 
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evident in the zone of TIRF illumination (Figure 2.14A and Video 7A).  To evaluate a role 
for myosin II in this activity, YTS cells were pretreated with the myosin light chain kinase 
inhibitor ML-9, which inhibits myosin II function (Saitoh et al., 1987).  ML-9 was used in 
this capacity for TIRF applications due to the phototoxicity of blebbistatin at 488 nm 
(Kolega, 2004).  ML-9-treated cells still polarized lytic granules toward the antibody-
coated glass (Figure 2.14A), but there were fewer lytic granules in the zone of TIRF  
     
 
Figure 2.13. Functional association of lytic granules with F-actin and effects of 
ATP and myosin IIA 1933x.   
Isolated lytic granules were added to flow chambers containing biotinylated BSA/streptavidin 
(BSA/SA) without actin, with actin and physiologic salt buffer, or with actin and ATP-containing 
high-salt buffer, or with actin using blebbistatin-treated granules.  Granules from YTS-MyoIIA-
GFP (A), control NK (C), and 1933x NK (D) cells were drawn through the chamber and 
allowed to flow through or adhere for 1-2 min before imaging with a confocal microscope at 
approx. 5 time points per second. From any single culture propagated NK cell preparation the 
quantity of lytic granules obtained was sufficient for flow through only two chambers.  Images 
were analyzed using the object tracking function in Volocity software and represent an overlay 
of 12 to 45 seconds.  Individual moving objects which had displacement greater than 5 µm 
(red) and displacement less than 5 µm (white) are indicated. Scale bar = 40 µm.  Some 
images are rotated from their original orientation, shown in Videos 4A-6B. (B,E) Number of 
moving objects per second ±SD in 3-5 independent sequences of isolated YTS-Myosin IIA-
GFP (B) and control and 1933x NK cell (E) lytic granules added to flow chambers.  *= p<0.05. 
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Figure 2.14.  Evaluation of myosin IIA in lytic granule dynamics.   
(A) Control or ML-9-treated YTS cells with polarized lytic granules (as determined by confocal 
fluorescent microscopy, at left) were imaged on an anti-CD28-coated glass surface using 
TIRFm for 30 seconds at a rate of 5 images per second.  Scale bar = 5 µm.  Representative 
cells of 11 individually analyzed cells for each condition are shown and were chosen based 
upon their representation of the median number of tracks of all cells analyzed.  (B) Change in 
area over time for individual granules in the representative cells.  y-axis was divided at 1 µm
2
 
as exceeding values were likely not to represent individual granules but rather conglomerates.  
(C) Mean ±SD lytic granule area for the cells depticted in (A,B) is shown over the number of 
timepoints representing the mean duration of tracks in ML-9-treated cells.  The mean number 
of timepoints in the control-treated YTS cell tracks (red) was less than in the ML-9-treated 
cells (blue).  (D-I) The total number of tracks (D), mean track length (E), mean track velocity 
(F), mean number of timepoints for tracks (G), mean track displacement (H), mean track 
displacement rate (I) plotted to show each of 11 independent control and ML-9-treated 
replicate cells, ±SD.  Red points in each condition indicate the representative cell shown in (A) 
and (B).  Difference between the means of control and ML-9-treated cells in (D,E,F,H) was 
significant (p<0.05), and in (I) demonstrates a trend (p<0.1).  TIRF microscopy was performed 
with the assistance of Gregory Rak. 
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illumination.  Furthermore, the lytic granules which were apparent were less dynamic 
(Figure 2.14A and Video 7B). 
 To quantify the effect of ML-9 treatment on lytic granule dynamics, individual lytic 
granules from multiple control and ML-9-treated cells were identified, measured, and 
tracked throughout the duration of imaging.  In control cells, granule area fluctuated over 
time, suggesting that granules were constantly moving toward and away from the NK 
cell membrane.  In ML-9-treated cells, however, granule area was generally small and 
remained constant throughout imaging (Figure 2.14B,C). Relative to control, ML-9-
treated cells had a lower mean number of lytic granule tracks (Figure 2.14D), which had 
less velocity, track length, total displacement and rate of displacement (Figures 
2.14D,F,H,I).  The mean duration of each track was not different between control and 
ML-9-treated cells (Figure 2.14G).  Thus, lytic granule approach to and movement at the 
IS is diminished by ML-9 treatment. This suggests a critical role for myosin II in this 
prefinal step in NK cell cytotoxicity, where lytic granules traverse the cell cortex to reach 
the NK cell plasma membrane. 
Discussion 
 NK cell cytotoxicity occurs largely through the directed exocytosis of lytic granule 
contents onto target cells.  Previously, myosin IIA was shown to be dispensable for NK 
cell conjugation with target cells, IS formation, and lytic granule polarization towards the 
IS, but required for degranulation (Andzelm et al., 2007).  Here, using NK cells from four 
patients with a mutation in myosin IIA, we identify a mechanism for myosin IIA function in 
NK cells.  Specifically, myosin IIA associates with lytic granules and enables their 
interaction with F-actin as well as their final approach to the IS. 
 This function of myosin IIA is likely critical, as there is a substantial accumulation of 
F-actin at the IS, which could prevent a large organelle such as a lytic granule (up to 1 
µm in diameter (Burkhardt et al., 1990)) from reaching the cell membrane. Clearances in 
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cortical actin have been identified at the secretory domain in CTLs (Stinchcombe et al., 
2001b) and subsequently in NK cells (Vyas et al., 2001).  It was unclear, however, 
whether lytic granules require assistance in navigating a course through the actin cortex 
surrounding the secretory domain once they have reached the IS.  In our studies of 
myosin IIA 1933x patient or blebbistatin-treated NK cells, we have found diminished 
colocalization between perforin and F-actin at the IS (Figure 2.2), suggesting that 
functional myosin IIA is necessary for lytic granule penetration into the F-actin cortex at 
the IS.  Myosin IIA is unlikely to function at the lytic IS in large-scale restructuring of F-
actin, as overall F-actin organization at the IS was previously reported as normal in 
blebbistatin-treated cells (Andzelm et al., 2007), although minor contributions of myosin 
IIA at the IS in readjusting the actin cortex cannot be excluded.  
 In the present work, we found that myosin IIA was directly and constitutively 
associated with lytic granules using several techniques (Figures 2.2,2.6,2.8).  Although 
we identified myosin IIA in lytic granule preparations in both YTS and donor-derived NK 
cells (Figure 2.8), it is possible that myosin IIA was present in these preparations due to 
an association with organelles of similar density to lytic granules.  This is unlikely, 
however, as myosin IIA was visualized with isolated lytic granules by confocal 
microscopy (Figure 2.8) and was at the periphery of lytic granules in ultrastructural 
analyses of intact eNK cells and isolated lytic granules (Figure 2.10).  Localization at the 
periphery of these organelles is important because this would allow myosin IIA to serve 
a functional role on intact granules.  The constitutive association of myosin IIA with lytic 
granules (Figures 2.6,2.8,2.9) suggests that myosin IIA is unlikely to be recruited to lytic 
granules upon NK cell activation, although rapid turnover of granule-associated myosin 
IIA cannot be excluded.  The association of myosin IIA with lytic granules would be akin 
to the functions of certain myosin isoforms in other cell types.  Examples include myosin 
V (reviewed in (Langford, 2002)) and myosin II (DePina and Langford, 1999; DePina et 
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al., 2007; Heimann et al., 1999; Ikonen et al., 1997; Neco et al., 2008; Neco et al., 2004), 
which are implicated in vesicle transport.  Myosin IIA, specifically, has also been linked 
to degranulation in mast cells (Holst et al., 2002; Ludowyke et al., 2006), although it is 
unclear whether myosin IIA is associated with mast cell granules or is involved in 
remodeling the cytoskeleton in these cells.  Our findings expand upon the role of myosin 
IIA in organelle transport, indicating a specialized and direct role for myosin IIA in the 
transport of NK cell lytic granules. 
 The association of myosin IIA molecules to lytic granules could potentially occur 
directly through the granule membrane.  The C-terminal fragment of myosin IIA can bind 
to phosphatidylserine-containing vesicles (Li et al., 1994; Murakami et al., 1994), and 
this property could enable a similar association with lytic granules.  Alternatively, myosin 
IIA may associate with lytic granules in an indirect fashion, as demonstrated by the 
cooperative binding of myosin V with rab27a and melanophilin to melanosome 
membranes (Wu et al., 2006).  Since myosin IIA has been previously identified in NK 
cells to exist in a complex with WIP and WASp (Krzewski et al., 2006), and WIP has 
been identified in NK cell lytic granule preparations (Krzewski et al., 2008), myosin IIA 
could potentially associate with lytic granules through this complex.   
 The specific association of myosin IIA with lytic granules may point to an inherent 
ability of lytic granules to reach the cell membrane once delivered to the cortex.  Myosin 
IIA-associated lytic granules isolated from NK cells are capable of adhering to F-actin, 
even under the force of flow (Figure 2.13).  The sensitivity of this interaction to ATP and 
high salt implies that the protein or proteins responsible are regulated by ATP, a known 
property of myosins.  There is a possibility that other actin-binding proteins associated 
with the granules may stabilize this interaction, but additional ATP-dependent actin-
binding motor proteins were not identified in our proteomic analysis of lytic granule 
contents (data not shown), or in those published by others (Casey et al., 2007).  A role 
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for myosin IIA in the final approach of lytic granules to the IS was further identified in ML-
9-treated NK cells using TIRF microscopy (Figure 2.14), despite the fact that granule 
polarization occurred (Figure 2.14A), as previously demonstrated (Andzelm et al., 2007).  
This implies a role for myosin IIA in transporting lytic granules to the plasma membrane 
following their delivery to secretory domains at the IS.  This function is likely to be 
specific for lytic granules, as IFN-γ secretion was not affected in blebbistatin-treated cells 
(Figure 2.4), a distinction further supported by studies defining differential regulation of 
degranulation and IFN-γ production in NK cells (Colucci et al., 2001; Vahlne et al., 2008). 
 The role for myosin IIA in NK cell lytic granule function was additionally 
demonstrated by NK cells from rare patients with May-Hegglin Anomaly due to a 1933x 
mutation in myosin IIA.  Patient NK cells had defective cytotoxic activity and lytic 
granules which poorly colocalized with F-actin (Figure 2.1), again suggesting that 
functional myosin IIA may be necessary for lytic granule entry into F-actin at the cell 
cortex.  While one of the four patients we evaluated had an atypical infection (with 
Listeria) which has been shown to involve NK cell-mediated defense (Berg et al., 2005), 
it is presently unclear if this defect is of clinical significance due to the small number of 
patients available for study with this mutation.  A more comprehensive clinical 
assessment of patients with this particular, as well as other, MYH9 mutations is 
warranted. 
 The 1933x mutation affects the domain of myosin IIA involved in filament formation 
and cargo binding (Murakami et al., 1994).  It does not prevent formation of heavy chain 
dimers, but does result in abnormal bipolar myosin IIA filaments (Franke et al., 2005).  
These potential effects of myosin IIA 1933x in filament formation and/or cargo binding 
suggest two different mechanisms of how myosin IIA associates with lytic granules.  
First, myosin IIA could form bipolar filaments which wrap around lytic granules.  In this 
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case, the presence of the 1933x mutant in myosin IIA heterohexamers would alter 
filament structure and reduce F-actin binding capabilities, potentially due to poor filament 
contractility.  Our data demonstrate that the quantity of myosin IIA associated with lytic 
granules is normal in patient NK cells (Figure 2.8), but the function in interacting with F-
actin is decreased (Figures 2.11,2.13).  As a second potential mechanism, several 
myosin IIA molecules could associate with NK cell lytic granules in single hexameric 
units.  Although one independent myosin IIA unit would have minimal processivity, 
multiple molecules could cooperate to enable granule interaction with F-actin (De La 
Cruz and Ostap, 2004). Single myosin IIA units attached to granules might lead to the 
directional rolling of granules along F-actin, while myosin IIA filament-wrapped granules 
might predict more random dynamics of individual granules.  Further studies defining 
these interactions hold the potential to identify novel mechanisms of myosin IIA function. 
 Regulation of myosin IIA could also represent an important means for controlling lytic 
granule interaction with F-actin, and may be affected by the 1933x mutant myosin. A 
casein kinase II phosphorylation site exists at S1943 of the myosin IIA heavy chain 
(Murakami et al., 1998), and is removed by the 1933x mutation.  Additionally, PKC-
mediated phosphorylation of S1916 (Conti et al., 1991; Moussavi et al., 1993) could be 
altered in the 1933x protein, as interaction of PKC with myosin IIA may be stabilized by 
the C-terminus of the protein.  Regulation of myosin IIA through C-terminal 
phosphorylation has been established in murine T cells (Jacobelli et al., 2004), 
suggesting that mutations disrupting phosphorylation sites may alter immunologic 
functions.  The 1933x mutation may also affect interactions with mts1/S100A4, which is 
known to bind between residues 1909-1937 of myosin IIA and regulate myosin IIA 
phosphorylation states (Kriajevska et al., 1998).  Alterations in myosin IIA 
phosphorylation state could result in decreased function in binding to or movement 
across F-actin. 
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 In cytotoxic lymphocytes, lytic granules are brought to the secretory domain by the 
MTOC, which approximates the cell membrane in cytolytic conjugates (Stinchcombe et 
al., 2006).  Myosin IIA may facilitate the final transport of NK cell lytic granules through 
the F-actin cortex at the IS.  Given that NK cells maintain abundant lytic granules at rest, 
this mechanism of tight control may be warranted.  Additional identification of how 
myosin IIA is regulated to promote lytic granule exocytosis may therefore uncover 
important controls for NK cell cytotoxicity.  The constitutive and functional association of 
myosin IIA with lytic granules, however, defines a critical requirement for accessing NK 
cell activity. 
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Chapter 3: Phosphorylation of the myosin IIA tailpiece regulates 
association of single myosin IIA molecules with NK cell lytic 
granules to promote NK cell cytotoxicity 3 
 
Summary 
 Natural killer (NK) cells are innate immune lymphocytes that provide critical defense 
against virally infected and transformed cells.  NK cell cytotoxicity requires the formation 
of an F-actin rich immunological synapse (IS), as well as the polarization of perforin-
containing lytic granules to and secretion of their contents at the IS.  We have previously 
reported that NK cell cytotoxicity requires nonmuscle myosin IIA function, and that 
granule-associated myosin IIA mediates the interaction of granules with F-actin at the 
IS.  Here, we evaluate the nature of the association of myosin IIA with lytic granules.  
Taking the lead from NK cells from patients with mutations in myosin IIA, we find that the 
nonhelical tailpiece is required for NK cell cytotoxicity and the phosphorylation of 
granule-associated myosin IIA.  Using ultra-resolution imaging techniques, we 
demonstrate that single myosin IIA molecules associate with NK cell lytic granules via 
the nonhelical tailpiece. We also find that phosphorylation of myosin IIA at residue 
S1943 in the tailpiece is needed for this linkage. This defines a novel mechanism for 
myosin II function, where myosin IIA can act as a single-molecule actin motor, claiming 
granules as cargo through tail-dependent phosphorylation for the execution of a prefinal 
step in human NK cell cytotoxicity. 
                                                        
3 A version of this chapter has been submitted for publication as: 
 
Sanborn KB, Mace EM, Rak GD, Difeo A, Martignetti JA, Pecci A, Bussel JB, Favier R, Orange JS. 
Phosphorylation of the myosin IIA tailpiece regulates association of single myosin IIA molecules 
with NK cell lytic granules to promote NK cell cytotoxicity. 
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Introduction 
Natural killer (NK) cells are lymphocytes of the innate immune system that provide 
critical defense against viral infections and cancer.  NK cells respond to infected or 
transformed cells by directly killing the target cells, and also secrete cytokines and 
provide co-stimulation to promote immune responses (reviewed in (Vivier et al., 2008)).  
NK cell activation takes place in a series of steps, beginning with adhesion signaling and 
the dynein-mediated convergence of lytic granules to the microtubule organizing center 
(MTOC, (Davis et al., 1999)). Following early adhesion signaling, the NK cell forms an 
array of adhesion and activation receptors termed the immunological synapse (IS, 
reviewed in (Orange, 2008)).  The IS is stabilized by these receptor interactions, as well 
as the polymerization of a dense layer of filamentous actin (F-actin) at the contact site 
(Carpen et al., 1983). Once an NK cell forms a mature IS, NK cell activation directs the 
polarization of lytic granules along with the MTOC to the IS (Mentlik et al., 2010).  When 
the NK cell secretory machinery has polarized in the direction of a target cell, lytic 
granule contents, including the pore-forming molecule perforin and apoptosis-inducing 
granzymes, are secreted at the plasma membrane and direct target cell lysis (reviewed 
in (Hoves et al., 2009)). 
Although NK cell lytic granules are delivered to the IS via association with 
microtubules and can dock at the plasma membrane for secretion, the dense layer of F-
actin at the IS may present a barrier to secretion of granule contents at the plasma 
membrane (reviewed in (Sanborn and Orange, 2010)).  Thus, transport across actin 
filaments may be required for lytic granules to reach the plasma membrane. As ATP-
dependent motor molecules that generate movement across actin filaments, members of 
the myosin superfamily are ideal for this role.  Myosin superfamily members have critical 
roles in immune cells, and are required for cell motility, migration, and adhesion (Deng et 
al., 1999). In NK cells, nonmuscle myosin IIA has been defined as a critical regulator of 
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NK cell cytotoxicity (Sanborn et al., 2009).  Myosin IIA is a hexameric protein composed 
of two heavy chains, two regulatory light chains, and two essential light chains (reviewed 
in (Eddinger and Meer, 2007)).  The N-terminal head portion of the heavy chain is 
important for its ATPase function and actin binding, while the C-terminal rod domain and 
nonhelical tailpiece are critical for regulating filament formation and cargo binding 
(reviewed in (Ricketson et al., 2010)).  Myosin IIA function is required for NK cell 
cytotoxicity, as NK cells treated with the myosin II inhibitor blebbistatin or with siRNA 
against myosin IIA have reduced cytotoxicity against target cells (Andzelm et al., 2007).  
Although myosin IIA is not required for conjugation with target cells, IS formation, or lytic 
granule polarization to the IS (Andzelm et al., 2007), it does associate with NK cell lytic 
granules (Sanborn et al., 2009). The motor function and tailpiece of myosin IIA are 
required for the interaction of lytic granules with F-actin (Sanborn et al., 2009),  and thus 
the requirement for myosin IIA is specific to lytic granule exocytosis due to its role in 
enabling granule localization into F-actin at the IS.  The mechanism for the requirement 
for the tailpiece and the nature of the association of myosin IIA with lytic granules, 
however, remain unclear. 
Mutations in the myosin IIA heavy chain, MYH9, cause several disorders including 
May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein 
syndrome, which are now collectively known as MYH9-related disease (MYH9-RD).  
MYH9-RD is characterized by macrothrombocytopenia and leukocyte inclusions, with 
mutations in some regions of the protein causing the occurrence of additional symptoms 
such as cataracts, deafness, and glomerulonephritis (Seri et al., 2003).  While immune 
function is not typically evaluated in patients with MYH9-RD, we previously identified a 
deficiency in NK cell cytotoxicity in patients with a C-terminal truncation of MYH9 at 
position 1933 (Sanborn et al., 2009).   In the present study, we evaluate the role of each 
major functional region of myosin IIA in NK cell cytotoxicity using NK cells from patients 
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with MYH9-RD, and define a specific requirement for the myosin IIA head domain and 
nonhelical tailpiece.  We further demonstrate that myosin IIA interacts with lytic granules 
as a single molecule rather than as a filament, an interaction that is regulated by 
phosphorylation of the myosin IIA tailpiece at residue Ser1943. 
 
Results 
Human NK cells with mutations in the myosin IIA head or tailpiece have impaired 
cytotoxicity.   
We have previously demonstrated that a truncation mutation in the tailpiece of 
myosin IIA reduces NK cell cytotoxic function (Sanborn et al., 2009).  To further examine 
the role of each region of myosin IIA in NK cell function, we evaluated patients with 
MYH9-RD due to mutations in each portion of MYH9.  Common clinical findings in 
MYH9-RD include macrothrombocytopenia, leukocyte inclusions, cataracts, deafness, 
and nephritis (Seri et al., 2003).  The patients in this study demonstrated some or all of 
these depending on their specific MYH9 mutation (Table 3.1), in accordance with 
previous reports of variable effects of MYH9 mutations (Pecci et al., 2008).  To 
determine the effect of these mutations upon NK cell cytotoxicity, ex vivo NK (eNK) cells 
from these patients were prepared from peripheral blood and evaluated for their ability to  
     
Table 3.1. Mutations and phenotype of patients with MYH9-RD.  
Position of mutation of each patient with MYH9-RD is listed, along with the presence of 
symptoms including macrothrombocytopenia, Döhle bodies, presenile hearing loss, 
glomerulonephritis, and cataracts.  n.d., not determined.  Clinical evaluation of patients was 
performed by Drs. James Bussel and Alessandro Pecci. 
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kill K562 erythroleukemia cells. 
The N-terminal head region of MYH9 is critical for binding to F-actin and ATP 
hydrolysis for motor function, which requires the flexibility of the neighboring 
subfragment 2 (S2) portion for myosin head motility (Eddinger and Meer, 2007).  NK 
cells derived from patients with the S96L mutation in the head region and T1155I 
mutation in the S2 region (Figure 3.1A) demonstrated a reduced ability to lyse K562 
target cells compared to control eNK cells (Figure 3.1B), suggesting a role for myosin IIA 
motor function in NK cell cytotoxicity, in accordance with previous studies (Sanborn et 
al., 2009). In contrast, although the helical rod portion of myosin IIA is critical for  
                          
Figure 3.1.  Effect of naturally occurring mutations in MYH9 on human NK cell 
cytotoxicity.   
(A) Schematic depicting the major functional regions of a myosin IIA molecule, indicating the 
position of MYH9 mutations in patients whose NK cells were used in this study. (B) Cytotoxic 
activity of negatively selected, purified ex vivo human NK cells from patients with mutations in 
the head (S96L), S2 (T1155I), rod (R1400W, D1424N), and tail (5779delC) domains of MYH9 
was compared to control donors in 
51
Cr-release assays against K562 target cells.  Results from 
1933x patients are previously published, and are shown for comparison.  Results are listed as 
lytic units required for 10% lysis of target cells (LU10), and patient cell LU10 is normalized to 
control for each assay. Where more than one patient with a specific mutation was analyzed, 
the mean +SD is shown. 
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formation of bipolar myosin II filaments (Franke et al., 2005), two mutations in the rod 
region, R1400W and D1424N (Figure 3.1A), affected cytotoxicity to a lesser extent 
(Figure 3.1B).  The variability in cytotoxicity of NK cells from patients with the D1424N 
mutation may be due to variable penetrance of the mutation and instability of the mutant 
protein, as suggested in other studies (Deutsch et al., 2003). 
The nonhelical tailpiece at the C-terminus of myosin IIA is required for binding to 
cargo, as well as for regulation of the protein (Sandquist and Means, 2008).  This area 
can also bind to regulatory elements at residues 1916 and 1943, as well as to 
phospholipid membranes (Fath, 2005).  We previously demonstrated that a truncation of 
the nonhelical tailpiece at residue 1933 diminishes NK cell cytotoxicity (Sanborn et al., 
2009).  Similar to patients with the 1933x truncation mutation, eNK cells from a patient 
with the 5779delC mutation (Figure 3.1A), which causes a frameshift at residue 1927 
that results in a truncation of the protein at residue 1942 (Kunishima et al., 2001b), have 
reduced cytotoxic function compared to control cells (Figure 3.1B).  Although studies of 
additional patients with MYH9 mutations are needed, these results suggest a specific 
requirement for myosin IIA motor function and its nonhelical tailpiece in NK cell 
cytotoxicity. 
                       
 
Figure 3.2.  Expression of GFP-tagged myosin IIA and mutants.  
Western blot of whole cell lysate from YTS cells and YTS cells expressing GFP alone (YTS-
GFP), wild-type myosin IIA-GFP (MIIA-GFP), 1933x myosin IIA-GFP (1933x-GFP), or S1943A 
myosin IIA-GFP (S1943A-GFP).  Evaluation of GFP and myosin IIA signal was performed on a 
fluorescence scanner, and overlay of GFP (red) and myosin IIA (blue) signal is shown in the 
top panel (250 kDa), as well as GFP alone in the bottom panel (25 kDa). 
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The myosin IIA tailpiece is phosphorylated at Ser1943.   
Because our results from patients with MYH9-RD suggested a specific requirement 
for the MYH9 tailpiece in NK cell cytotoxicity, we wanted to determine the nature of this 
requirement.  Thus we generated an NK cell model system to study the role of the MYH9 
tailpiece as instructed by the patient observations and created a YTS NK cell line 
expressing the MYH9 1933x truncation (hereafter referred to as 1933x) as a GFP fusion 
protein (YTS-1933x-GFP).  These cells expressed the 1933x-GFP protein at levels of 
approximately 20% that of endogenous myosin IIA (Figure 3.2).  Similar to patients with 
the 1933x mutation, the presence of the mutant myosin in YTS-1933x-GFP cells led to 
reduced cytotoxicity compared to cells expressing a wild-type myosin GFP fusion protein 
(YTS-MyoIIA-GFP).  This was most readily apparent in 51Cr-release assays against 
721.221 target cells with incubation times less than 4h (Figure 3.3). This may be due to 
the presence of two copies of endogenous, non-mutated myosin IIA in the cell line, 
unlike the patients, which are heterozygous for the 1933x mutation. 
The tailpiece of myosin IIA is a site of regulation by phosphorylation in many cell 
types (Conti et al., 1991; Jacobelli et al., 2004; Ludowyke et al., 2006; Murakami et al., 
1998).  To evaluate the phosphorylation of the myosin tailpiece, we immunoprecipitated  
                                   
 
Figure 3.3.  The 1933x mutation in MYH9 reduces NK cell killing.   
Cytotoxic activity of the YTS NK cell line stably expressing a 1933x myosin IIA-GFP fusion 
protein was compared to YTS cells expressing wild-type myosin IIA-GFP in 
51
Cr-release 
assays against 721.221 target cells.  Results are listed as lytic units required for 20% lysis of 
target cells (LU20), and 1933x-GFP LU20 is normalized to MIIA-GFP for each assay.  Results 
shown are the mean of three experiments, and error bars indicate SD. 
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the GFP-tagged wild-type and 1933x myosins from resting NK cells and NK cells 
conjugated to KT86 target cells, then compared their phosphorylation states.  In all 
cases, GFP immunoprecipitation resulted in the isolation of both GFP-tagged and 
untagged myosin IIA (Figure 3.4A – upper band is the GFP fusion protein, and lower 
band is endogenous), indicating that the two populations of myosin in the cells were able 
to complex with each other.  In GFP immunoprecipitates from cells expressing wild-type 
myosin IIA, gel staining for phosphorylation revealed substantial phosphorylation of the 
GFP-tagged myosin IIA as well as the endogenous protein (Figure 3.4A).  The amount of 
phosphorylation did not change upon conjugation with target cells.  Compared to YTS-
MyoIIA-GFP cells, YTS-1933x-GFP cells demonstrated reduced phosphorylation of the 
GFP-tagged protein, although equivalent quantities of protein were precipitated and the 
endogenous protein remained phosphorylated (Figure 3.4A).  Since we had previously 
defined an association of myosin IIA with NK cell lytic granules (Sanborn et al., 2009), 
we next wanted to specifically evaluate lytic granule-associated myosin IIA.  Thus, 
granules were isolated from YTS-MyoIIA-GFP and YTS-1933x-GFP cells and treated 
with 2M NaCl to remove peripherally associated proteins for immunoprecipitation.  
Similar to whole cells, immunoprecipitation of GFP-tagged myosins from lytic granule-
associated proteins demonstrated that granule-associated myosin IIA is constitutively 
phosphorylated, and that the 1933x mutation decreases phosphorylation (Figure 3.4B).  
This suggests that the MYH9 tailpiece is required for myosin IIA phosphorylation in NK 
cells. 
Because residue Ser1943 is a key site of myosin IIA phosphorylation (Moussavi et 
al., 1993) and is removed by the 1933x truncation, we wanted to determine whether 
Ser1943 is phosphorylated in NK cells.  Using GFP immunoprecipitates from whole cell 
lysate and isolated lytic granules, we evaluated Ser1943 phosphorylation in MyoIIA-GFP 
and 1933x-GFP expressing YTS cells with an antibody specific for phospho-Ser1943.  
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Figure 3.4.  Myosin IIA is constitutively phosphorylated at Ser1943.  
(A-D) YTS cells expressing wild-type myosin IIA-GFP (MIIA) or 1933x myosin IIA-GFP 
(1933x) were left resting or were conjugated to KT86 target cells.  GFP-tagged proteins were 
immunoprecipitated from lysates (A,C) or from the supernatants of isolated lytic granules that 
were treated with NaCl to remove surface proteins (B,D).  GFP immunoprecipitates were 
evaluated by gel stain for phosphorylation (Pro-Q) and total protein (Sypro) (A-B), or by 
Western blot for phospho-Ser1943 and total myosin IIA (C-D).  In (A-D), numbers below blots 
indicate the ratio of the phosphorylated band intensity to the total protein intensity for the 
GFP-tagged protein (upper band), normalized to the ratio for MIIA. (E) Resting and stimulated 
ex vivo human NK cell lysates and lytic granules isolated from resting eNK evaluated by 
Western blot for phospho-Ser1943 and total myosin IIA.  In each image there are two myosin 
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Wild-type myosin IIA was constitutively phosphorylated at Ser1943 in both whole cell 
lysate and isolated lytic granules (Figures 3.4C-D).  Due to the truncation upstream of 
the residue in 1933x myosin, the 1933x-GFP protein did not demonstrate Ser1943 
phosphorylation, however, the presence of the mutated myosin did not affect 
phosphorylation of Ser1943 in endogenous myosin IIA (Figures 3.4C-D).  To determine 
whether this phosphorylation was specific to our cell line or common to human NK cells, 
we evaluated the phosphorylation of myosin IIA from human eNK cells, as well as in 
eNK cell lytic granules.  In eNK cells and granules, myosin IIA was also phosphorylated 
at S1943 (Figure 3.4E), suggesting that regulation of myosin observed in NK cell lines is 
similar to that in primary human NK cells, and that the MYH9 tailpiece was required for 
its phosphorylation.  
Phosphorylation of myosin IIA at Ser1943 is required for NK cell cytotoxicity.   
Since we found that S1943 is phosphorylated in NK cells, and that cells expressing 
truncated myosin IIA lacking this residue (1933x) were impaired in cytotoxic activity, we 
wanted to determine if there was a specific requirement for S1943 phosphorylation in NK 
cell function.  Thus, we generated a YTS cell line expressing GFP-tagged myosin IIA 
with an S1943A mutation, which would therefore be unphosphorylatable at residue 1943 
(YTS-S1943A-GFP). 
  These cells expressed GFP-tagged S1943A myosin IIA at approximately 20% of 
endogenous myosin levels, similar to MyoIIA-GFP and 1933x-GFP cells (Figure 3.2). 
The YTS-S1943A-GFP cells, however, had reduced levels of cytotoxicity compared to 
both MyoIIA-GFP and 1933x-GFP cells (Figure 3.5A-B).  This reduction in cytotoxic  
bands: the larger corresponds to 253 kDa and represents the myosin IIA GFP fusion; the smaller 
corresponds to 227 kDa and represents the endogenous myosin IIA.  The inclusion of 2 heavy 
chains in each myosin hexamer enables association of exogenous and endogenously expressed 
myosin IIA molecules when evaluated via immunoprecipitation (see also Figure 3.2).  Results 
are representative of three (A-E, eNK) or two (E, LG) independent assays. 
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activity of S1943A-GFP cells was present in both one and four hour assays, although 
S1943A-GFP cells demonstrated detectable cytotoxic activity at four hours.  The 
reduced killing in these cells was not due to impaired viability, as all cell lines were >95% 
viable by flow cytometry for Annexin V and 7AAD (not shown).  Additionally, the YTS-
S1943A-GFP cells were as capable of conjugating to 721.221 target cells as MyoIIA-
GFP and 1933x-GFP cells (Figure 3.6A), and also secreted IFN-γ at similar levels upon 
conjugation (Figure 3.5C), suggesting that other effector functions requiring NK cell 
activation were intact.  Compared to YTS-MyoIIA-GFP, S1943A-GFP cells demonstrated 
reduced phosphorylation of the GFP-tagged protein in GFP immunoprecipitates (Figure 
3.7).  This effect was similar to that in the 1933x-GFP expressing cells.  These results  
        
 
Figure 3.5.  Myosin IIA phosphorylation at Ser1943 is required for NK cell 
cytotoxicity, but not IFN-γ secretion.  
Cytotoxic activity (A-B) and IFN-γ secretion (C) of YTS cells expressing wild-type myosin IIA-
GFP (YTS-MyoIIA-GFP), 1933x myosin IIA-GFP (YTS-1933x-GFP), or S1943A myosin IIA-
GFP (YTS-S1943A-GFP) was measured against 721.221 target cells.  Cytotoxicity was 
measured at at 1h (A) and 4h (B) after conjugation by 
51
Cr-release assay. (C) IFN-γ secretion 
into supernatant was measured 24h after conjugation by ELISA and calculated by subtracting 
IFN-γ secretion of NK cells alone.  In all experiments, results are the mean of three 
independent assays and error bars indicate SD. 
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suggest that Ser1943 is a primary site for phosphorylation in myosin IIA, which is 
specifically required for NK cell cytotoxicity. 
Ser1943 phosphorylation mediates the interaction of myosin IIA with lytic 
granules.   
In order to determine the mechanism of the impact of S1943A-GFP myosin expression 
on NK cell killing, we examined conjugates of YTS-MyoIIA-GFP, 1933x-GFP, and 
S1943A-GFP NK cells with 721.221 target cells using immunofluorescence confocal 
microscopy.  Compared to the YTS-MyoIIA-GFP cells, 1933x-GFP and S1943A-GFP 
cells formed equally mature synapses with target cells, with polymerization of F-actin at 
the IS and polarization of GFP-tagged myosin to the region of F-actin accumulation 
(Figure 3.8A).  While perforin also polarized to the IS in cells expressing the mutant 
myosins, colocalization of perforin fluorescence with GFP fluorescence was diminished 
in 1933x-GFP and S1943A-GFP cells compared to YTS-MyoIIA-GFP (Figure 3.8B, 
42.05% perforin volume colocalized with GFP in MyoIIA-GFP, vs. 20.77% and 20.15% in 
1933x- and S1943A-GFP).  This suggests that that the mutant myosin molecules were  
less capable of associating with NK cell lytic granules.  The ability of the GFP-tagged  
                                     
 
Figure 3.6.  Expression of myosin IIA mutants does not affect conjugation with 
target cells. 
YTS cells expressing wild-type myosin IIA-GFP (MIIA-GFP), 1933x myosin IIA-GFP (1933x-
GFP), or S1943A myosin IIA-GFP (S1943A-GFP) were allowed to conjugate to PKH26 dye-
loaded 721.221 target cells for 30 minutes.  Conjugation was evaluated by flow cytometry and 
is depicted as percent of total GFP
+
 NK cells in conjugate.  Results are representative of three 
independent assays. 
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myosin mutants to associate with lytic granules was evaluated using Western blot 
analysis of isolated lytic granules from YTS-MyoIIA-GFP, 1933x-GFP, and S1943A-GFP 
cells.  Compared to YTS-MyoIIA-GFP cells, the GFP signal as a feature of total granule 
protein, as well as the detectable myosin IIA, was reduced in granules from 1933x-GFP 
and S1943A-GFP cells (Figure 6C), indicating that the association of the myosin mutants 
with lytic granules is reduced. Overall, these data suggest that an intact myosin IIA 
tailpiece and phosphorylation of myosin IIA are required for association with lytic 
granules. 
Myosin IIA associates with lytic granules in single-molecule form via the tailpiece.   
Because phosphorylation of myosin IIA via its tailpiece was required for its linkage to 
lytic granules, we sought to determine whether myosin IIA associates with granules via 
the tailpiece directly.  Although many myosin classes are known to associate with cargo 
in single-molecule form, using the tail for cargo binding (Akhmanova and Hammer, 
2010), myosin II family members are typically considered to exist in filaments.  To 
determine the mechanism of myosin IIA association with lytic granules, granules were 
isolated from YTS NK cells and prepared for platinum rotary shadowing electron 
microscopy (EM), a technique that highlights three-dimensional structures (Svitkina, 
2009). The lytic granules, which were adhered to glass coated with anti-myosin IIA  
                    
 
Figure 3.7.  Ser1943 is a major site of phosphorylation in myosin IIA. 
GFP-tagged proteins were immunoprecipitated from lysates from YTS cells or YTS cells 
expressing wild-type myosin IIA-GFP (MIIA), S1943A myosin IIA-GFP (S1943A), or 1933x 
myosin IIA-GFP (1933x).  GFP immunoprecipitates were evaluated by gel stain for total 
phosphorylation (Pro-Q) and total protein (Sypro).  The larger of the two bands represents 
the myosin IIA-GFP fusion and the smaller the endogenous myosin IIA. Results are 
representative of three independent experiments. 
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Figure 3.8.  The myosin IIA tailpiece and S1943 phosphorylation are required for 
its interaction with lytic granules. 
(A) Confocal fluorescent micrographs of YTS cells expressing wild-type myosin IIA-GFP 
(MyoIIA-GFP), 1933x myosin IIA-GFP (1933x-GFP), or S1943A myosin IIA-GFP (S1943A-
GFP) conjugated to 721.221 target cells (721).   Differential interference contrast (DIC, left) in 
addition to fluorescent signal for actin (red), perforin (blue), GFP-myosin (green) are shown 
along with an overlay of fluorescent channels (right).  Scale bar, 5 µm.  (B) Percent of total 
perforin fluorescent volume colocalized with GFP volume +SD.  >20 cells per condition were 
analyzed.  (C) Western blot of isolated lytic granules from resting YTS cells or YTS cells 
expressing wild-type myosin IIA-GFP (MIIA), 1933x myosin IIA-GFP (1933x), or S1943A 
myosin IIA-GFP (S1943A).  GFP, myosin IIA, and granzyme B (GzmB) blots are shown.  
Imaging and analysis were performed with the assistance of Emily Mace. 
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antibody, demonstrated emanating structures with an appearance and dimensions 
characteristic of myosin IIA molecules (Figure 3.9A).  The lytic granules measured an 
average of 420 nm in diameter, consistent with estimates of lytic granule size.  Similarly, 
the long, rod-like domains of the associated structures had a mean length of 194 nm, 
consistent with the length of the myosin IIA rod domain (Fath, 2005).  To verify that the 
molecules present around the periphery of the lytic granules were myosin IIA and to gain 
greater insight into their arrangement, isolated granules were evaluated in ultra-
resolution using stimulated emission depletion (STED) microscopy (Huang et al., 2010).  
Our images had a resolution of 54 nm, as determined by measuring single fluorophore-
conjugated antibody signal (not shown).  If myosin IIA associated with NK cell lytic 
granules in filamentous form, the distance between tailpiece regions of adjacent 
molecules would be expected to be a consistent 14.3 nm, equivalent to the stagger of 
myosin IIA molecules in filaments (Straussman et al., 2005), which would appear as a 
continuous string of myosin IIA signal surrounding the granule at 54 nm resolution.  In 
contrast to this prediction, isolated lytic granules labeled with an antibody against the 
myosin IIA tailpiece demonstrated a distance of approximately 73-380 nm between 
myosin molecules (Figure 3.9B-C), with a mean of 179.8 nm over three images.  
Furthermore, the distance between molecules was irregular (standard deviation of 86 nm 
in distance between molecules), making a large ordered complex of myosin IIA 
molecules unlikely.  Taken together, these results suggest an association of single 
irregularly spaced molecules of myosin IIA with lytic granules via the tailpiece.  They 
more broadly define a mechanism by which a prefinal step for human NK cell cytotoxicity 
is governed through the tail-dependent phosphorylation and function of lytic granule-
associated myosin IIA, which claims granules as cargo. 
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Figure 3.9.  Single molecules of myosin IIA associate with NK cell lytic granules. 
Lytic granules were isolated from resting YTS cells and evaluated by platinum rotary 
shadowing EM (A) and STED microscopy (B-C).  (A) YTS cell lytic granule with emanating 
structures resembling myosin IIA, which are highlighted in color in the image at right.  Scale 
bar, 200 nm.  (B) YTS cell lytic granule visualized with an antibody against the myosin IIA 
tailpiece (green, left).  The distance between myosin IIA antibody molecules was measured 
using a line drawn around the periphery of the lytic granules (white, right).  Scale bar, 500 nm.  
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Discussion 
Previously, we demonstrated that myosin IIA is associated with NK cell lytic granules 
and facilitates the interaction of granules with F-actin at the IS for exocytosis (Sanborn et 
al., 2009).  This role for myosin IIA required its motor function and tailpiece, yet the 
mechanism for the association of myosin with the granules was unclear.  We sought to 
further examine the role for myosin IIA in NK cell lytic granule exocytosis by determining 
which portions of the protein are required for NK cell cytotoxicity.  Studies of NK cells 
from patients with mutations in MYH9 point to a requirement for the motor function and 
tailpiece, as rod mutations in MYH9 had a lesser effect on NK cell cytotoxicity (Figure 
3.1).  Because the rod domain is important for regulating intermolecular interactions 
during filament formation (Ricketson et al., 2010), and at least one of the mutations 
examined has been shown to alter the periodicity of myosin IIA rods (D1424N (Franke et 
al., 2005)), these results suggest that the ability to form bipolar filaments is not required 
for this function of myosin IIA. These data provide a clinical relevance to the role of 
myosin IIA in NK cell killing, and raise an additional consideration in patients with MYH9-
RD.  
While the requirement for the motor domain of myosin IIA in lytic granule exocytosis 
was likely due to the need to translocate granules across actin filaments (Sanborn et al., 
2009), the role of the nonhelical tailpiece was less clear.  Unlike the 1933x truncation 
mutation, which removes the entire tailpiece of myosin IIA, a greater portion of the 
tailpiece remains intact in the 5779delC myosin, which also affected NK cell killing  
(C) Normalized intensity plot along the line drawn at the periphery of the lytic granule shown 
in (B).  Numbers at top indicate the distance between adjacent antibody molecules.  Results 
are representative of >10 (A) or 3 (B-C) images.  (D) Proposed model of myosin IIA 
interaction with NK cell lytic granules.  Unphosphorylated myosin IIA tailpiece obscures the 
binding site for lytic granules (highlighted in turquoise).  Myosin IIA tailpiece phosphorylated 
at S1943 bends backward onto the rod, revealing the putative granule binding site.  1933x 
myosin IIA is missing a large portion of the granule binding site, and therefore can not sustain 
an interaction with granules under force.  S1943A myosin IIA has an intact tailpiece but 
cannot be phosphorylated, and therefore cannot reveal its putative granule binding site. 
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(Figure 3.1).  This also leads to a truncation (Kunishima et al., 2001a), albeit smaller, 
and suggests that the requirement for the tailpiece may be a feature of the amino acid 
sequence rather than related to tail or filament structure.  In this light, the C-terminus of 
myosin IIA is a key site of phosphorylation in many cell types, including mast cells 
(Ludowyke et al., 2006) and human T cells (Jacobelli et al., 2004).  In order to 
understand the importance of regulation via the myosin IIA tailpiece, we created a YTS 
NK cell line expressing GFP-tagged 1933x myosin, which demonstrated a cytotoxicity 
defect only at early time points (Figure 3.3).  This may be due to the presence of 
sufficient endogenous myosin IIA, however, it is also possible that the 1933x myosin is 
capable of associating weakly with the lytic granules, allowing it to partially assist in 
granule exocytosis as discussed below.  In attempting to gain greater insight, we 
observed that the mutant myosin from YTS-1933x-GFP cells or lytic granules prepared 
from these cells demonstrated reduced phosphorylation (Figure 3.4), suggesting that the 
tailpiece of myosin IIA is required for phosphorylation of the entire protein.  This is due to 
the phosphorylation of S1943, as this site was phosphorylated in wild-type myosin IIA 
and is absent in the truncated 1933x protein.  We also found that S1943 was 
phosphorylated in ex vivo human NK cells (Figure 3.4E), indicating that this mechanism 
of regulation is not exclusive to our cell line.  When we evaluated the role of this residue 
specifically, we found that S1943A myosin-expressing cells formed conjugates with 
target cells and secreted IFN-γ adequately, but had diminished cytotoxicity, suggesting 
S1943 phosphorylation directly regulates the function of myosin IIA in lytic granule 
exocytosis 
Since mutations of the rod domain of myosin IIA, which regulates filament formation, 
did not affect NK cell cytotoxicity (Figure 3.1), the requirement for the MYH9 tailpiece 
suggested that it may directly mediate granule attachment using a S1943 
phosphorylation dependent mechanism.  This is based upon our observation that cells 
 
74
expressing S1943A-GFP myosin demonstrated reduced cytotoxicity and association of 
the GFP-tagged myosin with perforin-containing granules (Figures 3.5 and 3.8). Images 
of lytic granules using two different ultra-resolution techniques suggested that myosin IIA 
is attached to NK cell lytic granules via its tail, as best visualized using platinum rotary 
EM, and is not present in large radial filaments, as determined by irregularly spaced 
fluorescent signal in STED imaging (Figure 3.9).  Although the STED images do not 
exclude the possibility that myosin IIA could exist in clusters or microfilaments on the 
granules, the large, irregular spacing of the molecules suggests that an association of 
large myosin filaments with lytic granules is unlikely.   To our knowledge, this work 
represents the first use of STED in for ultra-resolution evaluation of NK cell components.  
In light of these observations, we propose a model for the interaction of myosin IIA 
with NK cell lytic granules (Figure 3.9D). S1943 phosphorylation by casein kinase II has 
been suggested to cause the myosin IIA nonhelical tailpiece to bend back onto the C-
terminal portion of the rod domain, thus downregulating its ability to form filaments 
(Dulyaninova et al., 2005).  Since the tailpiece is also the location of lytic granule 
binding, in NK cells Ser1943 phosphorylation could additionally expose a binding site for 
lytic granules that is unavailable in the unphosphorylated protein. Therefore, constitutive 
phosphorylation of a pool of myosin IIA at Ser1943 would ensure that myosin IIA could 
interact with lytic granules.  In the case of the 1933x mutation, the truncated tailpiece 
may allow for weak binding of myosin IIA to lytic granules, however, this weak 
association would not enable myosin IIA to direct the motility of lytic granules across 
densely packed actin filaments at the IS.  Because the truncated myosin molecules 
could bind to both actin and the granules, however, they may act to stabilize the 
granules at the surface of actin, allowing for them to eventually reach the plasma 
membrane in the presence of sufficient wild-type myosin IIA, such as in the YTS-1933x-
GFP cells.  In the case of the S1943A point mutation, however, an unphosphorylatable 
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myosin tailpiece would remain in a conformation in which the binding site for lytic 
granules was obscured.  This would prevent any interaction with the lytic granules, 
potentially even in myosin IIA molecules in which one heavy chain is wild-type and the 
other is mutated.  This mechanism would explain our observed greater reduction in 
cytotoxicity in the YTS-S1943A-GFP cells compared to the 1933x-GFP cells, as the lytic 
granules in the former would be less capable of stably interacting with actin.  
While interacting with organelles in a single-molecule conformation represents an 
unconventional role for myosin IIA, previous reports have suggested a similar 
mechanism in other systems.  An interaction of myosin II with secretory vesicles has 
been demonstrated in diverse cell types (Seabrooke et al., 2010).  Furthermore, in clam 
oocyte extracts and Drosophila neurons, inhibition of myosin II activity reduces the 
motility of vesicles along actin (DePina et al., 2007), suggesting that myosin II can direct 
the motility of vesicles as cargo along actin filaments.  Although myosin IIA is not 
conventionally thought to be a processive motor, a recent study has suggested that 
myosin IIB may be processive across short distances (Norstrom et al., 2010), and thus, it 
is possible that once lytic granules are delivered to the IS, myosin IIA could direct the 
motility of lytic granules across short stretches of actin to the plasma membrane.  
Additionally, motor molecules that lack processivity as a single unit can still direct 
processive motion of cargo, provided that enough motors exist on the cargo that at least 
one is in contact with the track at all times (Gross et al., 2007).  Our data indicate that 
multiple myosin IIA molecules exist on each lytic granule (Figure 3.9A-C), and therefore 
the cooperation of these molecules may be sufficient to direct lytic granules across actin 
at the IS.  While the specific linkage between individual myosin IIA molecules and 
granules requires further study, the present results define a new role for myosin IIA in 
the immune system and in governing NK cell function, specifically that single molecule 
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tail-based associations to granules and myosin IIA tail phosphorylation are essential for 
accessing NK cell cytotoxicity. 
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Chapter 4: Discussion4 
Summary 
 NK cell cytotoxicity represents an important line of defense against infected and 
transformed cells, but this ability to kill other cells is, by necessity, tightly regulated.  An 
NK cell preparing to lyse a target cell must proceed through a series of steps, beginning 
with the initial ligation of tethering and adhesion receptors and ending with the secretion 
of lytic granule contents (Reviewed in Chapter 1 and (Orange, 2008)).  These steps are 
critically important to NK cell function, as NK cell functional deficiencies are reported in 
patients with mutations in proteins that are involved in each step (Orange, 2006). 
 In Chapter 2, we define a functional association of nonmuscle myosin IIA with lytic 
granules in NK cells.  We demonstrate that this association is critical to a final step of NK 
cell cytotoxicity, where lytic granules must travel through F-actin gathered at the IS to 
facilitate secretion of granule contents at the plasma membrane.  Myosin IIA motor 
function is required for the interaction of lytic granules with F-actin, suggesting that once 
polarized to the NK cell IS, lytic granules traverse the F-actin cortex using associated 
myosin IIA.  We also demonstrate a requirement for the nonhelical tailpiece of myosin 
IIA, as NK cells from patients with the 1933x truncation mutation in myosin IIA have 
reduced cytolytic function.  While the 1933x mutation does not prevent association with 
lytic granules, the granules are unable to interact with F-actin, thus implicating the 
nonhelical tailpiece of myosin IIA, in addition to its ATPase activity, in the interaction of 
lytic granules with F-actin. 
                                                        
4 Part of this chapter has been published as: 
 
Sanborn KB, Orange JS. 
Navigating Barriers: the challenge of directed secretion at the natural killer cell lytic immunological 
synapse. 
Journal of Clinical Immunology.  May 2010; Volume 30, pp.358-363. 
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 In Chapter 3, we further explore the requirement for each functional domain of 
myosin IIA.  We find that the head and S2 regions, as well as the tailpiece, are required 
for the function of myosin IIA in NK cell degranulation, while the rod domain is less 
important, suggesting that filament formation is not critical to this role for myosin IIA.  We 
demonstrate that myosin IIA associates with NK cell lytic granules in single-molecule 
form rather than in filaments, and that this interaction is regulated by phosphorylation of 
the nonhelical tailpiece at Ser1943.  This represents a novel mechanism of myosin IIA 
function in facilitating secretion. 
 Several questions remain regarding this role for myosin IIA and the nature of this 
step in the cytotoxic process.  In this chapter, I discuss the significance of our findings 
and potential areas of future research. 
Nature of myosin IIA association with lytic granules 
 We have demonstrated that myosin IIA associates with NK cell lytic granules to 
facilitate their transport through F-actin at the IS (Chapter 2).  This association requires 
the nonhelical tailpiece of myosin IIA, and is regulated by phosphorylation of the tailpiece 
at Ser1943 (Chapter 3).  The interaction of single molecules of myosin IIA with secretory 
vesicles as cargo is a novel finding, and therefore the precise nature of this association 
remains unclear.  Although the protein has been shown to localize to the outer 
membrane of lytic granules (Chapters 2 & 3), it is not known whether this association 
with the membrane is direct, or whether myosin IIA interacts with other proteins on the 
granule membrane.  Myosin IIA is capable of interacting directly with phosphatidylserine-
containing membranes (Li et al., 1994; Murakami et al., 1994), and therefore could 
potentially associate with lytic granules directly.  As the C-terminus is required for the 
association with membranes, this could explain the requirement of the nonhelical 
tailpiece for a strong association of myosin IIA with lytic granules.  Alternatively, myosin 
IIA may associate with lytic granules in an indirect fashion, via an interaction with 
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granule membrane-associated proteins.  This could be similar to the association of 
myosin V with melanosome membranes via a complex of rab27a and melanophilin (Wu 
et al., 2006).  Although this is perhaps a more likely mechanism of interaction with lytic 
granules, there are few proteins which have been characterized to interact with the C-
terminus of myosin IIA, other than the kinases PKC and CKII (Dulyaninova et al., 2005).  
Myosin IIA has been found in a complex with the actin-interacting proteins WIP and 
WASp in NK cells (Krzewski et al., 2006), and since WIP has been identified in NK cell 
lytic granule preparations (Krzewski et al., 2008), it is possible that the association of 
myosin IIA with lytic granules occurs through this complex.  Further studies of interaction 
partners for myosin IIA may provide additional information about how myosin interacts 
with NK cell lytic granules. 
Additional regulation of myosin IIA in NK cells 
 We have found that myosin IIA is constitutively associated with NK cell lytic granules, 
rather than being recruited to granules at the IS (Chapter 2).  This constitutive 
association suggests that additional regulation must occur in order for myosin IIA 
function to be confined to the IS.  Although myosin IIA is regulated by phosphorylation at 
Ser1943 to ensure a functional association with lytic granules (Chapter 3), since this 
phosphorylation is constitutive, and myosin IIA heavy chain lacking this residue 
(S1943A) has greatly reduced phosphorylation compared to wild-type myosin IIA, it is 
unlikely that any additional heavy chain phosphorylation of lytic granule-associated 
myosin IIA occurs specifically at the IS.  Thus, the function of myosin IIA in degranulation 
is likely to be regulated by light chain phosphorylation or by interaction with proteins 
specifically localized at the IS. 
 The motor activity of myosin IIA is heavily regulated by phosphorylation of its 
regulatory light chains.  Phosphorylation of the light chains at Ser19 generally increases 
the ATPase activity of myosin IIA, while phosphorylation at Ser1 and Ser2 
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downregulates its affinity for actin ((Adelstein and Conti, 1975; Nishikawa et al., 1984), 
reviewed in (Sellers, 1999)).  Thus, as myosin IIA activity would need to be selectively 
increased once lytic granules reach the NK cell IS, one could envision a scenario in 
which light chains are phosphorylated at Ser1/2 to downregulate myosin activity prior to 
granules reaching the IS, then dephosphorylated to increase the affinity of granule-
associated myosin for actin at the IS.  Alternatively, myosin IIA phosphorylation at Ser19 
could be downregulated by MYPT in resting cells, and the residue could be inducibly 
phosphorylated to promote myosin activity once lytic granules reach cortical F-actin.  
Both mechanisms may have a role in regulating granule-associated myosin IIA, and 
further studies focusing on the myosin IIA light chains may provide additional insight into 
regulation of lytic granule exocytosis. 
 In addition to regulation of the myosin IIA light chains, myosin IIA function may be 
facilitated by its interaction with proteins located at the IS.  Myosin IIA has been shown 
to interact with a complex of WIP and WASp at the IS in activated NK cells (Krzewski et 
al., 2006).  Because WIP and WASp are involved in F-actin reorganization, this 
interaction could potentially facilitate the transport of lytic granules across actin by 
stabilizing the interaction of the granules with F-actin at the IS.  Alternatively, if granule-
associated myosin IIA is involved in forming small conduits in actin for the lytic granules 
(see next section), the interaction with actin-regulating proteins could enable remodeling 
of F-actin for conduit creation. 
Another protein that may be involved in the regulation of myosin IIA is mts1/S100A4.  
Because mts1 binds to the tailpiece of myosin IIA, and can regulate phosphorylation 
status, an interaction with mts1 could determine whether myosin IIA is capable of 
binding to lytic granules.  Since granule-associated myosin IIA is phosphorylated at 
Ser1943 (Chapter 3), and Ser1943 phosphorylation downregulates the binding of mts1 
to myosin IIA (Dulyaninova et al., 2005), mts1 could potentially negatively regulate the 
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association of myosin with lytic granules.  This could be critical during the refractory 
period following target cell lysis, when lytic granule membrane must be recycled to 
create new granules for future cytotoxic activity.  Additionally, although the interaction of 
mts1 with myosin IIA has been demonstrated to regulate filament formation (Ford et al., 
1997; Li et al., 2003; Malashkevich et al., 2008), since its binding site in the tailpiece is 
near the region needed for interaction with lytic granules, it could potentially modulate 
the binding of myosin IIA to granule-associated proteins as well.  This could be a 
negative regulation, if mts1 competes for a binding site with other proteins, or its 
presence at the start of the nonhelical tailpiece could also facilitate the interaction of 
myosin IIA with a granule-associated protein. It is unlikely that mts1 binds directly to lytic 
granules, however, and therefore this would represent an additional layer of myosin 
regulation, not a mechanism of interaction with granules.  Further examination of the role 
of mts1 and other myosin-interacting proteins in NK cell degranulation could potentially 
uncover additional mechanisms of myosin IIA regulation. 
Role of F-actin at the IS and mechanisms of myosin IIA function in 
secretion 
 The role for myosin IIA in facilitating the interaction of lytic granules with F-actin for 
NK cell degranulation suggests that NK cells require actin-based motor function for the 
transport of lytic granules across F-actin.  The nature of this requirement, however, 
depends largely upon whether NK cells secrete lytic granule contents through large actin 
clearances or through smaller conduits in the actin network.  Lytic granule exocytosis in 
CTLs and NK cells has traditionally been thought to occur at F-actin-depleted regions.  If 
large clearances in actin are, indeed, the location of secretion for lytic granule contents, 
it remains unclear whether lytic granules are delivered directly to these clearances, or 
whether they must travel along actin filaments at the IS to reach an actin-sparse region 
in which they might reach the plasma membrane.  A recent study has shown that in 
 
82
CD4+ CTLs, lytic granules are initially delivered to the pSMAC region, while secretion of 
their contents occurs in the cSMAC (Beal et al., 2009).  The study did not elucidate the 
mechanism of transporting granules from the pSMAC to the cSMAC, and therefore it is 
unclear whether the movement requires travel along actin filaments or whether it is 
entirely microtubule-based.   While delivery of granules to the pSMAC has not been 
demonstrated in NK cells, in T cells, signal strength has been shown to play a role in 
which method of transport lytic granules use to reach the IS (Beal et al., 2009; Jenkins et 
al., 2009).  The strength of activation signaling vs. inhibitory signaling could therefore 
determine whether NK cell lytic granules are secreted in a region that is replete or 
relatively devoid of F-actin. If granules do, in fact, reach the membrane through actin-
free regions at the cSMAC, myosin IIA may have a role in the movement of lytic granules 
from the actin-dense pSMAC to large clearances at the cSMAC, allowing for the lytic 
granules to reach the plasma membrane upon reaching an actin clearance.      
 While large clearances in F-actin have been demonstrated in NK cells (Andzelm et 
al., 2007; Orange et al., 2003; Roda-Navarro et al., 2004; Vyas et al., 2001), and could 
be the location of directed secretion of granule contents, it remains unclear whether all 
F-actin at the IS is cleared away for secretion.  Recent data from our laboratory 
demonstrate that while the actin network is less dense at the center of the IS, filaments 
remain dense enough to present a barrier to secretion of granule contents (Gregory D. 
Rak, Tatyana Svitkina, and Jordan S. Orange, submitted).  This suggests that lytic 
granules are more likely to travel through smaller F-actin conduits rather than to be 
delivered directly to the plasma membrane at a large clearance in actin.  If lytic granules 
use smaller actin conduits rather than the cSMAC for secretion, the requirement for 
myosin IIA may be in directing the granules through these conduits.  Another possibility 
is that lytic granule-associated myosin IIA is directly involved in the creation of the actin 
conduits themselves.  Large-scale remodeling of actin at the IS in NK cells treated with 
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blebbistatin was normal (Andzelm et al., 2007), however, if myosin IIA is required for the 
creation or enlargement of small actin conduits, this could represent a novel function for 
this actin-based motor.   
 The physical challenge of the transit of a lytic granule of approximately 500 nm in 
size through the cell cortex is one which must, by necessity, require a solution.  The 
process may utilize different mechanisms at different points during IS formation, at least 
some of which are likely to involve significant interaction with actin filaments. Defining 
the precise function of myosin IIA in this process will likely require advanced imaging 
techniques, given the small size of the structures in question.  Further studies defining 
how lytic granules interact with F-actin will additionally clarify the role of actin-interacting 
and actin motor proteins in NK cell granule localization and degranulation. 
Requirement for myosin IIA in T cell vs. NK cell cytotoxicity 
 We have demonstrated a role for myosin IIA in facilitating lytic granule exocytosis for 
NK cell cytotoxicity (Chapters 2 and 3).  While myosin IIA has been shown to interact 
with NK cell lytic granules, it is unknown whether this interaction occurs in CTLs as well.  
Because their primary effector functions require exocytosis of lytic granules for target cell 
lysis, CTLs and NK cells are typically thought to use similar mechanisms to secrete 
granule contents.  This may not be correct however, as NK cells are innate immune 
lymphocytes and T cells are antigen-specific adaptive immune cells, and their signaling 
requirements differ. Differences in MTOC and lytic granule polarization have also been 
noted between the two cell types, as T cells have been shown to use signal strength-
dependent mechanisms of granule trafficking (Beal et al., 2009; Jenkins et al., 2009) and 
NK cell granules have been demonstrated to converge to the MTOC early on in the 
signaling process (Mentlik et al., 2010).  Furthermore, additional roles for myosin IIA 
have been defined in T cells that do not necessarily apply to T cells.  For instance, 
myosin IIA has a well-defined role in the regulation of T cell motility, migration, and IS 
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stability (Ilani et al., 2009; Jacobelli et al., 2009; Jacobelli et al., 2004; Jacobelli et al., 
2010).  Although these studies were primarily performed in CD4+ T cells, CD8+ T cells 
are expected to be similar (Jacobelli et al., 2010).  In contrast, although their migration 
has not been directly evaluated, NK cells treated with myosin II inhibitors or myosin IIA 
siRNA are capable of productive conjugation with target cells; can polarize actin, 
receptors, and perforin to the IS; and can secrete IFN-γ.  This suggests that T cell and 
NK cell IS formation may be differentially regulated, and therefore lytic granule 
exocytosis may occur through different mechanisms as well.  Evaluating the steps of the 
cytolytic process in T cells and NK cells may uncover unanticipated differences in how 
innate and adaptive cytotoxic lymphocytes are regulated. 
Implications for patients with MYH9-RD 
 We have defined a deficiency in NK cell cytolytic function in patients with MYH9-RD 
(Chapter 3).  As with several other symptoms of MYH9-RD, mutations in certain regions 
of the protein, in particular regions affecting motor function or the tailpiece, have a more 
substantial effect on NK cell cytotoxicity, suggesting that these regions are most 
important for the function of myosin IIA in NK cells. 
 Although several MYH9-RD patients have demonstrated reduced NK cell 
cytotoxicity, the patients we have evaluated generally do not experience rare or chronic 
viral infections (Table 1), as most patients with NK cell deficiencies do (Orange, 2006).  
While one patient with a 1933x mutation in myosin IIA experienced infection with 
Listeria, and another had Hepatitis C infection following a platelet transfusion, most 
patients remain immunologically competent.   It is unclear why these patients appear to 
be capable of fighting infections normally even though their NK cells do not have normal 
cytolytic capacity in vitro.  We have informally observed higher NK cell percentages in 
most MYH9-RD patients compared to controls, although these numbers remain in the 
normal range.  Combined with the fact that NK cell function is not entirely absent in the 
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patients, a slightly elevated NK percentage could account for the normal immune 
function in these patients.  Alternatively, it is possible that additional activation 
mechanisms could compensate for myosin-related effects in vivo. 
 Mutations in MYH9 are extremely rare, and therefore it is difficult to determine 
whether MYH9-RD has enough potential to affect NK cell activity to be considered a 
classical immune deficiency.  Nonetheless, although most of the patients we have 
evaluated have not experienced severe infections, the reduction in NK cell cytolytic 
function in patients with MYH9 mutations suggests that patients with MYH9-RD may be 
more susceptible to infections that require NK cell cytolytic function for defense.  This 
increased potential for serious infection should be considered by physicians when 
evaluating patients with MYH9-RD. 
Conclusions 
 This work has demonstrated a role for nonmuscle myosin IIA in NK cell lytic granule-
mediated cytotoxicity.  We have shown that myosin IIA constitutively associates with lytic 
granules to facilitate their interaction with F-actin at the NK cell IS.  This interaction is 
required for the exocytosis of lytic granule contents, and therefore represents an 
additional important step in directing target cell lysis.  Furthermore, we have 
demonstrated that single molecules of myosin IIA interact with lytic granules via their C-
terminal nonhelical tailpiece, and that this interaction requires phosphorylation of the 
tailpiece at residue Ser1943.  This represents a novel mechanism for myosin IIA in the 
transport of secretory vesicles.  Together, these results demonstrate that NK cells utilize 
an unconventional method of actin-based transport, whereby myosin IIA directs transport 
of lytic granules as cargo across F-actin to the plasma membrane for secretion. 
 Further studies of the series of steps involved in the cytotoxic process will be 
instrumental to our understanding of how NK cells are able to kill their targets.  The 
relationship of lytic granules with the MTOC and their ability to navigate F-actin 
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clearances once they reach the IS remain important areas of investigation.  Future 
studies of the role of myosin IIA in directing lytic granule exocytosis will focus on the 
precise nature of the association with lytic granules, additional regulation of granule-
associated myosin IIA, and the very nature of the clearances that allow for myosin-
dependent secretion of granule contents.  Understanding the steps that lead up to the 
directed secretion of lytic granule contents will allow for the possibility of restraining or 
augmenting NK cell function. 
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Chapter 5: Materials and Methods 
Cells 
Blood samples and ex vivo NK cell preparation. 
 PBMCs were prepared from whole blood obtained from patients or healthy volunteer 
donors using centrifugation through Ficoll-Paque Plus lymphocyte isolation medium 
(Amersham Biosciences). For Chapter 2, ex vivo NK (eNK) cells were prepared from 
PBMCs either by negative selection as described (Banerjee et al., 2007), or by FACS for 
CD56+CD3- lymphocytes in the cell sorting facility of Children’s Hospital of Philadelphia 
using a BD FACSVantage SE/DiVa cell sorter (BD Biosciences), and were used in 
experiments immediately after preparation. To expand eNK cells for granule preparation, 
isolated CD56+CD3- NK cells were co-cultured with irradiated allogeneic PBMCs and 
RPMI 8866 cells in RPMI 1640 media (Gibco) containing 5% human serum (Atlanta 
Biologicals), 500 U/mL human recombinant IL-2 (NIH AIDS Research and Reference 
Reagent Program), 5 x 10-5 M 2-mercaptoethanol (Gibco), and 2 µg/mL 
phytohemagluttinin (PHA, Sigma Aldrich).  Following establishment of the culture, 
additional irradiated allogeneic PBMCs and RPMI 8866 cells were added along with 2 
µg/mL PHA every 21-30 days and expanded NK cells were monitored over time to 
maintain near 90% NK cell purity. For Chapter 3, eNK cells were prepared from whole 
blood by negative selection using RosetteSep human NK cell enrichment cocktail 
(Stemcell Technologies).  For experiments biochemically evaluating eNK cells and lytic 
granules, eNK cells were prepared as described above from apheresis product obtained 
from individuals with hemoglobinopathy, which does not substantially alter NK cell 
granule content (data not shown). For samples from patients with MYH9-related 
diseases, mutation analyses were performed at Duke University, Mount Sinai School of 
Medicine, the Children’s Hospital of Philadelphia according to published methods (Kelley 
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et al., 2000).  All human samples were obtained with informed donor consent and were 
used with the approval of the institutional internal review board for the protection of 
human subjects at the Children’s Hospital of Philadelphia. 
Cell lines. 
  The immortalized NK cell lines YTS as well as YTS stably expressing GFP (YTS-
GFP), or one of three different myosin IIA-GFP fusion proteins: full length (YTS-MyoIIA-
GFP), 1933 truncated (YTS-1933x-GFP) or S1943A mutant (YTS-S1943A-GFP), were 
used as model NK cell systems and are described elsewhere (Banerjee et al., 2007) or 
generated as described below. 721.221 EBV-transformed B-lymphoblastoid cells, K562 
erythroleukemia cells, and K562 cells stably expressing CD86 (KT86, previously used 
and described (Banerjee et al., 2007)) were used as target cells.   
 To generate YTS-MyoIIA-GFP cells, 3 x 106 YTS cells were nucleofected using an 
Amaxa Nucleofector (Amaxa, Inc.) with 2 µg of linearized GFP-human nonmuscle 
myosin IIA heavy chain plasmid containing a neomycin resistance gene (Addgene) in 
Amaxa solution R (Amaxa Inc.), using nucleofection program O-017.  Transfected cells 
were selected in G418 sulfate (Cellgro) and repeatedly sorted by FACS to obtain a pure 
population of GFP-expressing cells. For the creation of MYH9-1933x-GFP and MYH9-
S1943A-GFP constructs, plasmid DNA encoding GFP-human nonmuscle myosin IIA 
heavy chain, described above, was modified to contain C5797T (1933x) or T5827G 
(S1943A) alterations in the coding region of the MYH9 gene.  Cell lines were created by 
nucleofection as described above. 
Flow cytometric, conjugation, and degranulation analyses. 
 eNK cells from patients, healthy volunteer donors, or apheresis donors were 
analyzed for expression of CD56 and CD3 using fluorophore-conjugated mAbs (BD 
Biosciences).  All ex vivo NK cell samples from whole blood used contained a mean 
purity of >72% CD56+CD3- cells.  YTS NK cell lines were analyzed for expression of 
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GFP, as well as for viability by staining with Annexin V-PE and 7AAD (BD Biosciences). 
YTS and eNK cell granzyme B and perforin content was evaluated by intracellular flow 
cytometry using fluorophore-conjugated mAbs (BD Biosciences). 
 For analysis of NK cell degranulation in Chapter 2, PBMCs were resuspended at a 
concentration of 1 x 106 cells/mL to which 1 x 105 K562 cells, 3µg/mL anti-CD28 and 
anti-CD49d (BD Biosciences), 0.7 µg/mL monensin (BD Biosciences), 1 µg/mL brefeldin 
A (Sigma-Aldrich) and anti-CD107a were added. Cells were incubated at 37˚C, 5% CO2 
for 5h, washed, stained for viability with Aqua amine-reactive viability dye (Invitrogen), 
and then stained with surface antibodies. K562 were not added to control samples. 
Antibodies for surface staining included anti-CD4 PE-Cy5-5 (Invitrogen) or PerCP-Cy5.5 
(BD Biosciences), anti-CD56 PE (BD Biosciences) and anti-CD107a FITC (BD 
Biosciences). The cells were then washed and permeabilized using the 
Cytofix/Cytoperm kit (BD Biosciences) according to the manufacturer's instructions and 
stained with anti-CD3 Qdot 585 for 1 hour, washed, and fixed in PBS containing 1% 
paraformaldehyde.  For each specimen, between 500,000 and 1,000,000 total events 
were acquired on a modified flow cytometer (LSRII; BD Immunocytometry Systems). 
Antibody capture beads (BD Biosciences) were used to prepare individual compensation 
tubes for each antibody used in the experiment. Data analysis was performed using 
FlowJo version 8.8.2 (TreeStar).  
 For analysis of NK cell conjugation with target cells and degranulation in Chapter 3, 
5x105 721.221 target cells were washed, resuspended in 5x10-5M PKH26 cell membrane 
dye (Sigma Aldrich) for 5min at 25°C, and labeling halted by the addition of FBS.  
Labeled target cells were then washed and allowed to conjugate with GFP-myosin 
expressing YTS cells at a 1:2 ratio in the presence of 1.2ng/µL PE-Cy5-conjugated 
CD107a antibody (eBioscience) at 37°C, after which conjugates were fixed with 1% 
paraformaldehyde and evaluated by FACS.  
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NK cell functional assays 
Myosin II inhibitors. 
NK cells were pre-incubated with 40 µM ML-9 (Sigma-Aldrich) in 0.5% ethanol, or 75 
µM blebbistatin (Sigma-Aldrich) in 0.0045% DMSO, for 30 min at 37ºC where indicated, 
as previously described (Andzelm et al., 2007). 
51Cr release cytotoxicity assay.   
Cytolytic activity was measured by 51Cr release assay, and where specified, lytic 
units calculated as described (Orange et al., 2002).  For cytotoxicity assay with isolated 
lytic granules, 3 x 106 cell equivalents of each density gradient fraction were washed and 
resuspended in PBS, then added to 1 x 104 51Cr–loaded 721.221 or KT86 target cells in 
HBSS along with 2 mM CaCl2.  To control for the protein contained in added granule 
fractions, target cells used for measuring the spontaneous release of 51Cr were 
suspended in 0.03% BSA in PBS with 2 mM CaCl2.  
NK cell IFN-γ secretion.  
  YTS NK cells were pre-incubated with blebbistatin or vehicle for 30 min at 37˚C, 
after which media or 721.221 target cells at a 2:1 effector to target cell ratio were added 
for 0, 4, or 22 hours (Chapter 2), or for 0 and 24 hours (Chapter 3). After incubation, cell 
supernatants were removed and frozen at -80˚C and then batch analyzed by IFN-γ 
ELISA (R&D Systems).  For analysis of eNK IFN-γ secretion, eNK cells were pre-
incubated with blebbistatin or vehicle, then incubated with 721.221 cells as described 
above for 22 hours. 
 
Biochemical assays 
Immunoprecipitation. 
For immunoprecipitation of GFP-tagged myosin from whole cell lysate, 3x106 GFP-
myosin expressing YTS cells were lysed in ice-cold lysis buffer (25mM Tris-Cl (pH 7.5), 
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150mM NaCl, 5mM MgCl2, 1% Nonidet P-40, 1mM DTT, 5% glycerol).  Lysates were 
pre-cleared by centrifugation at 14,000xg for 10 min, then incubated at 4°C for 1h on a 
rotating platform with Protein G-Agarose beads (Invitrogen) and anti-GFP antibody 
(Clontech 632460).  For immunoprecipitation from lytic granules, lytic granules were 
isolated as described below and resuspended in 2M NaCl for 20min at 25°C, then 
subjected to centrifugation at 18,000xg for 15min.  Supernatants from salt-treated 
granules were used for immunoprecipitation as described above. 
Western blot.  
 For Western blotting of total lysate, cells were lysed in ice-cold lysis buffer (25 mM 
Tris-Cl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% NP-40, 1 mM DTT, 5% glycerol).  
Proteins from 2.5 x 106 cell equivalents per sample were separated on a 4-12% Bis-Tris 
density gradient gel (Invitrogen) and transferred to nitrocellulose membranes 
(Invitrogen), which were blocked in 3% BSA and 140 mM NaCl Tris-buffered saline 
(TBS) and then incubated with the antibodies indicated below. For Western blotting of 
isolated lytic granules and related samples, 4-5.6 x 105 cell equivalents of density 
gradient fractions were separated and transferred as described above.  Membranes 
were incubated with the following antibodies: anti-myosin IIA (Sigma M8064), anti-
myosin IIA (Abcam 55456), anti-myosin IIA phosphoserine 1943 (ECM Biosciences), 
anti-granzyme B (Sigma), anti-actin (Sigma), anti-perforin (Diaclone) or anti-LAMP-1 (BD 
Biosciences).  The Sigma antibody to myosin IIA detects the C-terminus of the protein, 
while the Abcam antibody detects an internal epitope which is not truncated in the 1933x 
protein. Bound antibodies were detected with anti-rabbit or anti-mouse IgG coupled to 
fluorophores (AlexaFluor 680, Molecular Probes; IRDye 800, Rockland), and imaged 
using the Odyssey Infrared Imaging System (Li-Cor Biosciences).  Densitometric 
analysis was performed for Western blots using Li-Cor Odyssey software. 
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Isolation of lytic granules from NK cells.   
 1-3 x 108 YTS or YTS-Myosin II-GFP NK cells were lysed and homogenized using a 
Dounce homogenizer.  The homogenized lysates were subjected to centrifugation at 
1000g to remove the nuclei.  The postnuclear lysate (PNL) was subjected to 
centrifugation at 18,000g to pellet the lytic granules, yielding the crude lysosomal fraction 
(CLF).  The CLF was resuspended in extraction buffer and subjected to density gradient 
ultracentrifugation at 150,000g on an 8-27% Optiprep gradient (Lysosomal Isolation Kit, 
Sigma-Aldrich, or Lysosome Enrichment Kit, Pierce).  Fractions of 0.53 mL were 
harvested for further analysis.  For isolation of lytic granules from human NK cells, 1 x 
108 NK cells were isolated as described above from peripheral blood, and granule 
isolation was performed as described above.  Where specified for comparison to 
conjugated cell granules, 2 x 108 YTS or YTS-Myosin IIA-GFP NK cells and 1 x 108 
KT86 target cells were either incubated together at 37˚C for 30 min before being lysed, 
or were lysed and homogenized separately, and then mixed.  The lysates of both cell 
types were then subjected to the lytic granule isolation procedure described above. 
Biotinylation of isolated lytic granules.   
 The lytic granule density gradient fraction found by Western blot to contain the most 
granzyme B and myosin IIA was washed in PBS and divided into two equal-volume 
portions.  One portion was incubated with PBS pH 8.0 alone, while the second portion 
was incubated with EZ-Link Sulfo-NHS-SS-Biotin (Pierce) in PBS pH 8.0 at RT for 30 
min following manufacturer’s instructions.  Both portions were then washed 2X with ice-
cold PBS and lysed in 1% NP-40.  Lysed granules were pre-cleared at 8200g for 10 
minutes, then incubated with streptavidin-agarose beads (Millipore) at 4˚C for 1 hour.  
Beads were pelleted at 8200g, then washed 3X with ice-cold PBS.  Immunoprecipitated 
proteins were released from beads by boiling in LDS sample buffer (Invitrogen) and 
subjected to gel electrophoresis and Western blot as described above. 
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Serine esterase assay.  
 Equal volumes of each lytic granule isolation density gradient fraction were placed 
into a 96-well plate, to which a substrate solution consisting of PBS containing 9.8 mM 
HEPES (Gibco), 196 µM N-a-Cbz-L-lysine thiobenzyl ester hydrochloride (BLT, Sigma) 
in 1:1 acetic acid:ethanol, and 218 µM 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB, Sigma) 
in ethanol was added.  Whole cell lysate from 1-2.5 x 105 YTS cells was added to 
separate wells as a control.  Samples were incubated with substrate solution for 30 min 
at 37˚C, and following incubation, absorbance was measured at 415 nm. 
Actin-binding centrifugation assay.   
 F-actin was generated from purified G-actin using standardized reagents 
(Cytoskeleton, Inc.) according to manufacturer’s instructions and allowed to stabilize for 
14 hours at 23°C.  Isolated lytic granule samples from one fraction of the density 
gradient were incubated for 30 min at 23°C in the presence or absence of 3.83 µM F-
actin.  Actin bundling protein α-actinin was added at 20 µg/mL as a positive control.  
Samples were then precipitated by centrifugation at 18,000g, a force lower than needed 
to precipitate F-actin but suitable for precipitating lytic granules.  The precipitate and 
supernatant were evaluated for the presence of actin and granzyme B by Western blot. 
Actin-binding flow chamber assay.   
Purified G-Actin (11.5 µM, Cytoskeleton, Inc.) was polymerized using F-actin 
polymerization buffer (Cytoskeleton, Inc.) in the presence of 11 µM unlabeled phalloidin 
(Sigma-Aldrich), 0.85 µM biotinylated phalloidin (Molecular Probes), and 1.41 µM Alexa 
Fluor 647-labeled phalloidin (Molecular Probes), then allowed to stabilize for 4 hours at 
23°C.  50 mm coverslips (VWR) were coated with 10 µg/mL biotinylated BSA (Pierce), 
followed by 10 µg/mL streptavidin (Jackson ImmunoResearch), and where specified, 
followed by polymerized, phalloidin-stabilized F-actin.  A flow chamber was created by 
adhering a 40 mm coverslip (VWR) to each protein-coated coverslip using silicone 
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grease.  150 µL of isolated lytic granules from a density gradient fraction enriched in 
myosin IIA and granzyme B were washed in PBS at 18,000g, incubated with Lysotracker 
Red DND-99 for 30 min at 37˚C, washed, and resuspended in physiologic salt buffer (25 
mM KCl, 2 mM MgCl2, 20 mM HEPES pH 7.6).  Where specified, granules were also 
incubated with and maintained in 75 µM blebbistatin. Lytic granules were added to the 
flow chamber dropwise, and buffer drawn through the chamber using Whatman paper at 
the opposite end.  After granules had adhered to the slide despite continued buffer flow, 
high-salt/ATP (100 mM KCl, 2 mM MgCl2, 20 mM HEPES, pH 7.6, 5 mM ATP) solution 
was added to the chamber.  Granules were allowed to flow through or adhere to the 
chamber for 1-2 minutes before imaging with an Olympus IX-81 spinning disk confocal 
microscope at maximum speed (approximately 5 images/sec).  Images were analyzed 
using Volocity software, in which granules were defined as objects containing 2 SD or 
higher GFP intensity (for Myosin IIA-GFP cell granules) or Lysotracker Green intensity 
(for human NK granules).  Objects less than 1 µm2 in area were excluded as debris.  
The “Track Objects” function in Volocity was used following the “Shortest Path” tracking 
model, identifying moving objects as tracks.  Broken tracks were joined by the program 
using a maximum distance between objects of 20 µm to avoid identifying one moving 
granule as multiple tracks, and to allow accurate joining of fast-moving objects. Tracks 
with displacement greater than 5 µm were considered to be lytic granules in motion in 
the flow chamber, and were counted, then divided by the duration of the video to control 
for differences in imaging time.  For visualization of BSA/SA- and BSA/SA/Actin-coated 
flow chambers, separate flow chambers were made containing BSA/SA or BSA/SA and 
F-actin, stabilized with 11 µM AlexaFluor 488-labeled phalloidin (Molecular Probes).  
Flow chambers were visualized by TIRF microscopy as described above. 
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Mass spectrometry.   
Fractions of the lytic granule density gradient shown by Western blot to be enriched 
in granzyme B and myosin IIA were separated by electrophoresis on a 4-12% Bis-Tris 
density gradient gel (Invitrogen) which was stained with colloidal Coomassie.  Individual 
bands of interest were excised, digested with trypsin, and subjected to vacuum matrix-
assisted laser desorption (vMALDI) mass spectrometry as described (Krzewski et al., 
2006) in the Stokes Protein Core Facility of the Children’s Hospital of Philadelphia.  MS 
data was analyzed using Scaffold software (Proteome Software Inc). 
 
Imaging and image analysis 
Fixed cell microscopy.   
Conjugates between NK and target cells at a 2:1 ratio were formed in suspension for 
20 min and adhered to poly-L-lysine-coated glass slides (Polyprep, Sigma-Aldrich) for 15 
min, all at 37°C, as described (Sanborn et al., 2010).  Fixing, permeabilization, and 
staining were performed as previously (Sanborn et al., 2010), except the following 
reagents were used in the specified sequence.  For Chapter 2, the sequences used 
were: 1) anti-myosin IIA (Sigma) or rabbit IgG control (Sigma), or anti-myosin IIA 
(Abcam) or mouse IgG control; 2) anti-rabbit Pacific Blue (Invitrogen) or anti-mouse 
Pacific Blue (Invitrogen); 3) rabbit IgG (to block nonspecific binding); 4) unconjugated or 
FITC-conjugated anti-perforin clone ∆G9 (BD) or nonspecific IgG clone MOPC21 (BD, 
as a control); 5) Alexa Fluor 647-conjugated highly cross-adsorbed goat anti-mouse 
(Invitrogen), or AlexaFluor 647-conjugated phalloidin or 647-conjugated streptavidin 
control (Invitrogen). For Chapter 3, the sequence used was: 1) unconjugated anti-
perforin clone ∆G9 (BD) or nonspecific IgG clone MOPC21 (BD, as a control); 2) Pacific 
Blue-conjugated goat anti-mouse (Invitrogen) and AlexaFluor 647-conjugated phalloidin 
(Invitrogen).  All antibodies were used in the range of 0.6-20 µg/mL.  Slides were 
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covered with 0.15 mm coverslips (VWR Scientific) using mounting medium (Molecular 
Probes). Imaging was performed using a spinning disk confocal microscope (Olympus 
IX-81 DSU), and images analyzed using Volocity software (Improvision).  For evaluation 
of myosin IIA, GFP, actin, and perforin localization throughout the cell volume, 20-30 
images were acquired through the z-axis at 0.5 µm intervals and reconstructed using 
Volocity software.  
In all experiments, detection settings were adjusted so that control-stained samples 
were uniformly negative and experimentally stained samples were not saturating or 
emitting signal detectable using filter sets intended for imaging other fluorophores.  
Settings were not adjusted throughout the experiment to allow for quantitative 
assessment of signals.  The accumulation of fluorescent molecules was examined using 
the intensity threshold of 1.5-3.5 SD higher than the mean intensity of the fluorophore 
within the field. The area occupied by an accumulated fluorescence intensity was 
measured using this threshold, and the area of colocalization between different 
fluorescent molecules was determined by measuring the area containing two or more 
accumulated fluorophores.  The percentage colocalized was determined by comparing 
the area of colocalization to the total area occupied by a certain fluorophore.  Images 
shown have a similar intensity threshold applied for visualization as for analysis in order 
to facilitate the visualization of the fluorescent signal measured.  Analysis of perforin 
polarization to the IS was performed as described previously for MTOC polarization 
(Banerjee et al., 2007), using perforin fluorescence in place of α-tubulin.  Quantitative 
analysis of F-actin accumulation at the IS was performed as described previously 
(Banerjee et al., 2007), with the following modification: a series of 1 µm2 regions were 
generated to cover the IS, and the mean F-actin intensity measured and multiplied by 
the area of F-actin determined by applying the same threshold to all areas sampled. 
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Live cell microscopy.  
NK cells were loaded with Lysotracker Red DND-99 (Molecular Probes), incubated 
for 30 min at 37°C, washed, and resuspended in RPMI with 10% FCS.  KT86 or 721.221 
target cells were adhered to a ∆T dish (Bioptechs) pre-coated with anti-CD48 (BD, for 
721.221) or anti-CD58 (BD, for KT86) mAb for 30 min at 37°C.  Lysotracker-loaded NK 
cells were introduced to the ∆T dish at a 1.5:1 effector to target ratio, and cells were 
imaged in a single z-plane using an Olympus IX-81 spinning disk confocal microscope 
and Volocity Software (Improvision) every 15 seconds over the course of 20-30 min of 
conjugation.  Temperature was maintained at 37°C over the course of the experiment 
using ∆T dish heater and objective heater units (Bioptechs).  For analysis of 
colocalization over time, 3-5 images were chosen from ≥8 conjugates which contained 
visible lytic granules and represented stages of IS formation (recognition of target cell, 
lytic granule clustering and initial polarization, final stages of granule polarization).  
Values were averaged with others representing similar time after conjugation binned by 
1 min intervals.  Accumulation of fluorescent molecules was analyzed as described 
above for fixed cells, using a similar intensity threshold to define accumulation of 
fluorescent signal.  The area occupied by accumulated fluorescence was measured and 
the percent colocalized area determined for each time point. Images shown have a 
similar intensity threshold applied for visualization as for analysis in order to facilitate the 
visualization of the fluorescent signal measured.  
Total internal reflection fluorescence (TIRF) microscopy.   
4x105 YTS cells were loaded with 10 µM Lysotracker Green (Invitrogen), 
resuspended in 0.5 mL RPMI with 10% FCS, and added to anti-CD28 coated ∆T dishes 
(Bioptechs) heated to 37oC.   Cells were imaged through the z-axis 25 min after addition, 
using confocal microscopy to identify cells with granules polarized to the anti-CD28-
coated glass.  Cells were then visualized using a 90o side port on the same microscope 
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outfitted with a TIRF illuminator (Olympus) and an Argon 488nm laser (Melles Griot) with 
a 60x 1.45 NA objective.  Images were acquired in TIRF mode at the interface between 
the cell and glass over 30s at a rate of 5 images/sec.  Image streams were analyzed by 
cropping to the cell of interest, then further cropping to the cell footprint by applying an 
inclusive classifier to detect objects that fell above the mean intensity of the image.  
Objects within the cell having an intensity >3 SD above the mean intensity of all pixels 
and >0.05 µm2 were included for analysis.  Object tracks were identified over time using 
the Volocity Shortest Path tracking model set to join broken tracks with a maximum 
distance between objects of 0.05 µm.  Objects not assigned to a track, i.e. those that 
were present for only one timepoint, were excluded from analysis. 
Electron microscopy (EM).   
For EM of isolated lytic granules in Chapter 2, 200 µL of isolated lytic granules from 
YTS NK cells was washed in PBS at 18,000g and resuspended in 1 mL of immuno-EM 
fixative (4% paraformaldehyde, 0.1% glutaraldehyde, 0.1 M sodium cacodylate buffer pH 
7.4) for 18 hours at 4ºC.  After subsequent dehydration in ethanol, the sample was 
embedded in L.R.White resin and polymerized with UV light at -20ºC.  Ultrathin sections 
on nickel grids were treated with a blocking solution containing ovalbumin and cold water 
fish skin gelatin prior to incubation with anti-myosin IIA antibody (Sigma).  After multiple 
PBS washes, sections were treated with a goat anti-rabbit secondary antibody 
conjugated to 6 nm gold particles.  Sections were imaged in the Biomedical Imaging 
Core Facility of the University of Pennsylvania using a JEOL 1010 electron microscope 
fitted with a Hamamatsu digital camera system.  True immunogold labeling in images 
was identified using AMT imaging software by reducing gamma to 0.3.  Data shown, 
however, represent the original unmodified image. 
For EM of isolated lytic granules in Chapter 3, lytic granules were isolated as 
described above, then resuspended in PBS containing protease and phosphatase 
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inhibitor (HALT, Pierce) and seeded on glass coverslips coated with anti-myosin IIA 
antibody (Sigma) for 30 minutes at 37°C.  Coverslips containing lytic granules were 
prepared for platinum rotary shadowing EM as previously described (Orange et al., 
2011). 
STED microscopy.   
For STED microscopy, lytic granules were isolated from YTS cells as described 
above and seeded on Poly-L-lysine coated glass slides for 60 minutes at 37°C.  
Samples were prepared for imaging as previously described, and were treated with 
rabbit anti-myosin IIA antibody (Sigma), followed by DyLight 488 conjugated goat anti-
mouse antibody (BioLegend).  Samples were mounted using Prolong mounting medium 
containing anti-fade (Invitrogen).  STED images were acquired with a Leica STED CW 
system using an HCX APO 100X/1.4 oil STED objective.  Samples were excited with a 
488nm argon laser and depleted with a 592nm laser. 
 
Statistical analysis 
 For fixed and live cell microscopy, the minimum number of cells evaluated in a given 
experiment was determined using a sample size calculation based upon preliminary 
data, with α and β error levels of 1%.  For statistical analyses, differences between cell 
types or conditions were determined using an unpaired two-tailed Student’s t test, an 
exact Wilcoxon-Mann-Whitney test, or a Wilcoxon matched pairs test.  Differences were 
considered significant if p<0.05. 
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